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Abstract 
 
 
The “non-conventional” yeast Kluyveromyces lactis has become increasingly 
attractive for the industry and has been successively used in biotechnology mostly 
for the production of heterologous proteins. In this study, we demonstrated that the 
Klura3∆ and Klura5∆ mutants of the yeast K. lactis are able to produce and 
secrete into the growth medium significant amounts of orotic acid, an intermediate 
of the de novo pyrimidines biosynthetic pathway. Using yeast extract - peptone - 
glucose (YPD) based media, we optimized production conditions in flask and 
bioreactor cultures. With cells grown in YPD 5% glucose medium, the best 
production in flask was obtained using a 1 : 12.5 culture volume / flask volume 
ratio, 180 rpm, 28 ºC and 200 mM MOPS for pH stabilization at neutral values 
(initial culture pH at 8.0). The best production in a 2 L bioreactor was achieved at 
500 rpm with 1 vvm aeration, 28 ºC and pH 7.0. Under these optimum conditions, 
similar rates of orotic acid production were obtained and maximum concentration 
achieved after 96 h was 6.7 g/L in flask and bioreactor cultures. These results 
revealed an excellent reproducibility between both systems and provided evidence 
for the biotechnological potential of Klura3∆ and Klura5∆ strains since the amounts 
obtained are comparable to the production in flask using a similar mutant of the 
industrially valuable Corynebacterium glutamicum currently used in industry to 
produce orotic acid. 
We have also established the grounds for the development of a low cost 
production media for industrial scale-up. A media containing 4% (v/v) corn steep 
liquor (CSL), 3.4% (v/v) molasse, 0.25% (w/v) urea and 200 mM MOPS for pH 
stabilization at neutral values (initial culture pH at 8.0), which only had a total of 
2% (w/v) sugars, allowed the production of 4.5 g/L of orotic acid after 80 h. CSL 
proved to be very promising as the main low cost constituent of the production 
media. However, it contains inhibiting factors for the production of orotic acid, thus 
limiting the concentration of CSL that can be used in the media. Before further 
development of the industrial media, the inhibition caused by CSL should be first 
addressed to reduce or eliminate its effects in order to take full advantage of CSL 
benefits. 
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A putative link between the pyrimidines biosynthetic pathway and mitochondria led 
us to assess changes in the oxidative stress markers in the orotic acid producing 
mutants. Our results show that at latter stages of growth, catalase activity 
increased in pyrimidines mutants of K. lactis with the interruption at any step of the 
de novo pyrimidines pathway. Depending of the growth phase, the Klura3∆ mutant 
displayed a distinct or a more marked phenotype compared to other pyrimidine 
mutants, suggesting different mechanisms may be involved in this particular 
mutant. Notably, at latter stages of growth, the high catalase activity exhibited by 
Klura3∆ cells was correlated with an increased resistance to H2O2. Moreover, 
deletion of any of the dihydroorotate dehydrogenase genes (DHODases; Klura1∆ 
and Klura9∆) in Klura3∆ was shown to alter its phenotype, indicating a possible 
connection of the de novo pyrimidines pathway with oxidative stress response that 
involves Klura3p, Klura1p and Klura9p. 
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Resumo 
 
 
A levedura “não-convencional” Kluyveromyces lactis tem-se tornado cada vez 
mais atrativa para a indústria e tem sido usada com sucesso em biotecnologia 
sobretudo para a produção de proteínas heterólogas. Neste trabalho,  
demonstramos que os mutantes Klura3Δ e Klura5Δ da levedura K. lactis são 
capazes de produzir e secretar para o meio de crescimento quantidades 
consideráveis de ácido orótico, um intermediário da via de síntese de novo das 
pirimidinas. Usando meios de cultura baseados em extrato de levedura - peptona 
- glicose (YPD), otimizamos as condições de produção em matraz e biorreactor. 
Com células cultivadas em meio YPD 5% glicose, a melhor produção em matraz 
foi obtida com uma proporção de 1 : 12.5 para volume de cultura / volume de 
matraz, 180 rpm, 28 ºC e 200 mM MOPS para a estabilização do pH em valores 
neutros (pH cultura inicial a 8.0). A melhor produção num biorreator de 2 L foi 
alcançada a 500 rpm com um 1 vvm de arejamento, 28 ºC e pH 7.0. Sob estas 
óptimas condições, as taxas de produção de ácido orótico foram semelhantes e a 
concentração máxima atingida após 96 horas foi de 6.7 g / L em culturas de 
matraz e biorreactor. Estes resultados revelaram uma excelente reprodutibilidade 
entre os dois sistemas e fornecem evidências relativamente ao potencial 
biotecnológico das estirpes Klura3Δ e Klura5Δ, uma vez que os valores obtidos 
são comparáveis à produção em matraz com um mutante semelhante do 
microorganismo Corynebacterium glutamicum, que é actualmente usado na 
indústria para a produção de ácido orótico. 
Foram também estabelecidas as bases para o desenvolvimento de um meio de 
produção de baixo custo para “scale-up” industrial. Um meio contendo 4% (v/v) de 
água de maceração de milho, 3.4% (v/v) melaço, 0.25% (w/v) ureia e 200mM 
MOPS para estabilização do pH a valores neutros (pH 8.0 para início da cultura), 
contendo somente um total de açucares de 2%, permitiu a produção 4.5 g/L de 
ácido orótico após 80 h. A água de maceração de milho provou ser bastante 
promissora como o principal constituinte de baixo custo do meio de produção. 
Contudo, demonstrou-se conter fatores inibitórios para a produção de ácido 
orótico o que, por esse motivo, limita a sua concentração no meio de cultura. 
Previamente à continuação com o desenvolvimento do meio industrial, a inibição 
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causada pela água de maceração de milho deve ser primeiro avaliada para 
reduzir ou eliminar os seus efeitos de forma a poder usufruir de todas as suas 
vantagens. 
A existência de uma possível ligação entre a via de síntese de novo das 
pirimidinas e a mitocôndria levaram-nos as avaliar as alterações nos marcadores 
de stress oxidativo nos mutantes produtores de ácido orótico. Os nossos 
resultados mostram que em fases avançadas do crescimento, há um aumento da  
actividade da catalase nos mutantes de K. lactis com a interrupção em qualquer 
um dos passos da via de síntese de novo das pirimidinas. Dependendo da fase de 
crescimento, o mutante Klura3∆ apresentou um fenótipo diferente ou mais 
marcado quando comparado com outros mutantes da via das pirimidinas 
sugerindo que outros mecanismos poderão estar envolvidos neste mutante em 
particular. Em fases avançadas do crescimento, a elevada actividade de catalase 
exibida pelas células Klura3∆ correlacionou-se com um aumento da resistência ao 
H2O2. Mais ainda, a deleção de qualquer um dos genes que codificam para 
desidroorotato desidrogenases (DHODases; Klura1∆ e Klura9∆) no Klura3∆ 
alterou o seu fenótipo, indicando uma possível ligação da via de síntese de novo 
das pirimidinas com a resposta ao stress oxidativo que envolve a Klura3p, a 
Klura1p e a Klura9p. 
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1.1. The yeast Kluyveromyces lactis 
 
The yeast Kluyveromyces lactis owes its name to the Dutch microbiologist Albert 
Jan Kluyver (1888–1956) and to have been originally isolated from milk. Most 
microorganisms lack the enzymes to metabolize lactose and, besides lactic acid 
bacteria, enterobacteria and some filamentous fungi, K. lactis is one of the few 
exceptions that can grow in lactose as sole carbon source. For that reason, it can 
be found in milk and constitutes the predominant eukaryote during cheese 
production, which by decreasing the whey pH allows better conditions for the 
growth of lactic acid bacteria. 
K. lactis is closely related to Saccharomyces cerevisiae [1] (Figure 1.1) and shares 
similar morphologic and life cycle characteristics. It is a unicellular ascomyceteous 
yeast that divides by polar budding, having similar generation time as wild type 
strains of S. cerevisiae. K. lactis has a life cycle supported by two mating types, a 
stable haploid and a semi-stable diploid phase, and can be induced to produce 
tetrads by nutrient starvation [2]. However, interest in K. lactis arose from its 
distinctive physiological properties compared to the classical yeast model 
S. cerevisiae. Along with the fission yeast Schizosaccharomyces pombe and the 
non-fermenting Yarrowia lipolytica, K. lactis is one of the most studied 
“non-conventional” yeasts and has driven increased interest into fundamental 
research studies [3, 4]. 
 
 
1.1.1. Varieties and episomal DNA 
 
Two different varieties of K. lactis can be found: the domestic K. lactis var. lactis 
[5] and its wild relative K. lactis var. drosophilarum [6]. The taxonomic difference 
between the two varieties is based arbitrarily on phenotypic and ecological 
characteristics [7]. However, the most obvious metabolic difference is that the wild 
variety has lost the ability to ferment lactose, reflecting the silencing of KlLAC4 and 
KlLAC12 encoding β-galactosidase and lactose permease, respectively [8]. 
Therefore, for basic research purposes, the K. lactis research community has 
chosen to work with strain K. lactis var. lactis CBS 2359 (DSM 70799 from DSMZ). 
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K. lactis var. lactis is also the variety predominantly used in biotechnology. Unless 
named otherwise, further mention to K. lactis will be referring to K. lactis var. lactis. 
Some K. lactis strains contain a cytoplasmic linear DNA plasmid pair, pGKL1 and 
pGKL2, conferring the “killer” phenotype [9]. These plasmids are responsible for 
the production of an anti-yeast toxin complex known as zymocin. The toxin itself is 
encoded by pGKL1 whereas pGKL2 is responsible for the maintenance of pGKL1.
 
 
 
Figure 1.1 
 
 
Figure 1.1 Phylogenetic placement of species currently assigned to Kluyveromyces within the 11 clades of 
the Saccharomycetaceae. The tree is modified from that published by Kurtzman [10], which was based on a 
maximum parsimony analysis of sequences from the small-subunit rRNA gene, part of the internal transcribed 
spacer/5.8S region, three regions of the large-subunit rRNA gene, elongation factor 1K, the mitochondrial 
small-subunit rRNA gene and cytochrome oxidase II. The total number of species recognized in each genus 
proposed by Kurtzman [10] is shown. A complete branching network is given only for species in the genus 
Kluyveromyces. 
5 
5 
2 
6 
2 
5 
4 
Kluyveromyces aestuarii 
Kluyveromyces nonfermentans 
Kluyveromyces wickerhamii 
Kluyveromyces lactis 
Kluyveromyces marxianus 
Kluyveromyces dobzhanskii 
Lachancea 
Torulaspora 
Zygotorulaspora  
Zygosaccharomyces 
Tetrapisispora 
Nakaseomyces 
7 Saccharomyces 
18 Kazachstania 
Vanderwaltozyma 
Naumovia 2 
	  	   4	  
Studies using these strains provided insights into new mechanisms of microbial 
competition [11] and played an important role in the development of K. lactis 
biology, because at that time the only plasmids known in yeast were the 2 µm 
circular DNA and the double-stranded killer RNA of S. cerevisiae. pGKL1 and 
pGKL2 have been thoroughly studied and represent a model system for analyzing 
the fundamentals of linear plasmid replication and gene expression [12-14]. Also, 
the fact that K. lactis secreted a high-molecular weight killer toxin retained the 
attention of the bioindustry that was looking for an efficient system to produce 
recombinant proteins in a secreted form. Later, and after a deliberate search, a 
2 µm type circular plasmid pKD1 was discovered in K. lactis var. drosophilarum 
[15] that was capable of replicating in K. lactis var. lactis. This discovery was of 
considerable importance for K. lactis research by offering a replicating vector 
system equivalent to the S. cerevisiae 2 µm vectors and opened the way for the 
development of other derivatives vectors with improved characteristics. 
 
 
1.1.2. Carbon and energy metabolism 
 
Regulation of primary carbon and energy metabolism has been one of the main 
focus of K. lactis research since it reflects the adaption of K. lactis to aerobic 
conditions and contrasts with the well-studied but exceptional physiology of 
S. cerevisiae [16]. K. lactis assimilates a wider variety of carbon sources but the 
utilization of lactose is its characteristic trait and has been studied extensively. The 
studies on the lactose regulon in K. lactis illustrated how the regulatory system of 
this unicellular eukaryote differs from the bacterial lactose operon. This regulon, a 
close variation of the galactose regulon of S. cerevisiae, was shown to involve 
many genetically unlinked positive and negative regulatory genes [16, 17]. K. lactis 
displays the Kluyver effect, i.e., its growth on certain mono- and oligosaccharides 
(such as galactose, raffinose, sucrose and maltose) occurs only under respiratory 
conditions and not under oxygen-limiting conditions. Yeasts displaying this effect 
are yet capable of fermenting glucose as well as one or more components of these 
oligosaccharides [18]. This has been associated with low permease activities for 
these sugars, which are not sufficient to ensure the high substrate flow that is 
necessary for fermentative growth [19]. 
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K. lactis is a so-called “petite-negative” yeast in which maintenance of 
mitochondrial DNA and mitochondrial protein synthesis is essential [20]. It has a 
respiratory-fermentative metabolism and most strains can grow on fermentable 
carbon sources when respiration is blocked [21]. Nevertheless, K. lactis appears to 
be an obligate aerobe that is not able to grow under strict anaerobic conditions 
[22]. S. cerevisiae is a prototypical Crabtree-positive yeast since when provided 
with glucose it produces ethanol even under conditions of oxygen saturation [23]. 
On the other hand, K. lactis favors respiration over alcoholic fermentation and is 
Crabtree-negative due to the absence of aerobic ethanol formation [24, 25], thus 
increasing ATP and biomass yield when compared to Crabtree-positive yeasts 
[26]. The absence of glucose repression of respiration illustrates a major 
difference in the regulation of glucose metabolism as compared to S. cerevisiae. 
Once the central metabolite glucose-6-phosphate is produced, its further 
consumption differs significantly between K. lactis and S. cerevisiae. Whereas in 
the latter, most of the glucose consumed is metabolized through glycolysis 
producing NADH, in K. lactis it is mainly channeled into the pentose phosphate 
pathway [27] and as a consequence there is a higher production of NADPH in the 
cytosol. Another important difference in energy metabolism between K. lactis and 
S. cerevisiae concerns the fate of cytosolic NADH and NADPH, which needs to be 
oxidized to maintain the redox balance. A significant part of NADPH reoxidation is 
carried out in K. lactis by mitochondrial external alternative dehydrogenases, 
which can use both NADH and NADPH, in contrast to the enzymes of 
S. cerevisiae that are NADH-specific [28, 29]. In fact, one of the molecular keys 
supporting the difference in the Crabtree phenotype of the two yeast species lies 
in the mechanisms involved in the reoxidation of the NADPH [28]. 
 
 
1.1.3. K. lactis as model organism 
 
While S. cerevisiae preferably ferments in the presence of glucose, K. lactis favors 
respiratory growth. As opposed to S. cerevisiae cells, it has been described the 
strong resemblance to human of the regulatory circuits of K. lactis responses to 
hypoxic conditions [30]. Many yeast genes related to the hypoxic responses are 
related to human diseases [31]. Also unlike S. cerevisiae, K. lactis has not 
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undergone whole genome duplication and thus, does not produce enzymatic 
isoforms from paralogous genes. The existence of different protein isoforms 
makes the analysis of in vivo protein functions or complementation assays with 
human proteins challenging. Therefore, K. lactis has been considered a model 
more suitable than other yeasts to study basic cellular processes related to human 
diseases such as Alzheimer’s and Parkinson’s [30, 32]. 
 
 
1.2. K. lactis in biotechnology 
 
Despite their higher relative complexity, yeasts tend to have many beneficial, 
industrially attractive traits relative to commonly used  bacteria  such as  E. coli 
[33-36]. A few of these attributes include: growth to high cell densities on a wide 
variety of carbon sources, ability to perform a variety of post-translational 
modifications, potential to compartmentalize reactions in organelles, high secretion 
capacity, and a lack of susceptibility to infectious agents like bacteriophage [37]. 
S. cerevisiae is currently the dominant yeast in protein biochemistry, metabolic 
engineering and the production of fermented beverages. Over the years, K. lactis 
has received increasing attention from bioindustries, having now emerged as one 
of the most important non-Saccharomyces yeast species for industrial 
biotechnology, especially for the industrial production of proteins [4, 38, 39]. 
 
 
1.2.1. Food industry 
 
K. lactis has a GRAS (Generally Regarded as Safe) status making it an attractive 
production organism in the food industry [40, 41]. It possesses a broader and 
diversified catabolic repertoire compared to S. cerevisiae, thus enabling lower cost 
bioprocesses. In particular, the ability of K. lactis to use lactose allows it to grow on 
whey, which is an inexpensive waste product from the dairy industry. This is a 
major advantage over other types of yeasts due to the resulting economic and 
ecological benefits. The whey produced in industry constitutes a major 
environmental problem because of its high organic load [42, 43]. On the other 
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hand, it represents a cheap carbon source for K. lactis growth, since the price for 
the traditionally used molasses has increased considerably over the past decades. 
The Crabtree-negative phenotype of K. lactis is of great relevance for industrial 
production of metabolites and heterologous proteins since it can be advantageous 
for increasing biomass accumulation in aerated cultures without losing overflow 
carbon to undesired ethanol production. Swinkels et al. first reviewed in 1993 the 
use of K. lactis as a host for heterologous protein expression [41]. Eight proteins 
had been successfully secreted from K. lactis at that time. Since K. lactis rapidly 
achieves high culture densities and produces high yields of recombinant proteins, 
currently, nearly 100 heterologous proteins have been produced successfully in 
K. lactis and large-scale cultures of up to 140 m3 have been reported [39]. Proteins 
produced by K. lactis originate from bacteria, fungi, viruses, plants, and mammals, 
emphasizing the ability of K. lactis to efficiently produce a diverse range of 
heterologous proteins. 
Some of the most important current applications of K. lactis include the industrial 
production of proteins on an industrial scale in the food industry. Due to its ability 
to grow on lactose, K. lactis has been the natural choice for the production of its 
ß–galactosidase since the 1950s. This enzyme is used to produce lactose-free 
dairy products allowing the growing number of lactose-intolerant individuals to 
consume milk-based products. It is also used to produce pre-biotic 
galacto-oligosaccharides  (GOS)  by  exploiting  its   transglycosylation  activity 
[44, 45]. GOS are thought to reduce the level of cholesterol and to prevent colon 
cancer [46, 47] and are also used as low-calorie sweeteners [48]. ß-galactosidase 
is now produced on an industrial-scale and marketed under several trade names 
from distinct companies. To improve its production, vector systems, genetically 
modified yeast strains and adjustment of growth parameters are intensively 
investigated [49-52]. 
As a host for heterologous protein production, K. lactis is best known for its use in 
commercial production of recombinant bovine chymosin [53]. Showing a higher 
specific activity than traditional rennet, this milk-clotting enzyme is widely 
employed in the production of cheese. Bovine chymosin was the first heterologous 
enzyme originating from a higher eukaryote that was produced at low cost in a 
microorganism. The process developed for its industrial-scale production was 
widely recognized as a major biotechnological achievement and is now one of the 
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most widely used processes in the food industry. Other commercially relevant 
proteins produced using K. lactis include inulinase [54], phospholipase B [55], 
chitinase [56], xylanase [57], brazzein [58], glucoamylase [59] and 
α-L-rhamnosidase [60]. 
 
 
1.2.2. Pharmaceutical industry 
 
Given the success as a host for protein expression in the food industry, K. lactis 
was later introduced for large-scale production of therapeutic heterologous 
proteins in the pharmaceutical industry. Numerous proteins of pharmaceutical 
relevance have been produced in K. lactis to high titer. That was the case of 
human interleukin 1-β, used to treat autoimmune disorders [61, 62], interferon-α, 
used in cancer therapy [63, 64] and for the treatment of hepatitis [65], macrophage 
colony-stimulating factor (M-CSF), used to combat disorders of the hematopoietic 
system [66], and insulin precursors, used for diabetes therapy [67]. Furthermore, 
K. lactis is also proficient in the production of β-lactoglobulin [68], human serum 
albumin [69-71] and single-chain Fv antibodies [72, 73]. One drawback to the use 
of K. lactis (and other yeast and fungal expression systems) for the production of 
therapeutics is that secreted proteins that become glycosylated will bear a 
non-human glycosylation pattern due to its tendency to hyperglycosylate [74]. 
However, advances in the area of humanizing yeast protein glycosylation 
pathways have been applied in K. lactis demonstrating it can be modified to 
produce enzymes that mimic human glycosylation, as previously achieved in 
P. pastoris and S. cerevisiae [75, 76]. 
 
 
1.2.3. Metabolites production using K. lactis 
 
K. lactis, and other few non-conventional yeasts, have served as long-standing 
industrial protein production platforms. However, their utility in the small molecule 
chemical space is sometimes limited to native metabolite overproduction 
phenotypes. Nevertheless, several metabolites are produced commercially in 
K. lactis. These include lactic acid and glycolic acid [77], the sugar acid D-xylonic 
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acid (D-gluconic acid), which is derived from D-xylose [78], and D-arabitol, which 
is produced directly from whey [79]. 
 
 
1.3. Strain improvement and K. lactis molecular tools  
 
The development of suitable production strains requires the selection and 
engineering of a strain with the most appropriate properties. Over the past few 
decades, several factors have contributed to the success of S. cerevisiae, namely 
the existence of a well-established classical genetics, the availability of fast and 
efficient transformation procedures, a large number of integrative or autonomously 
replicating vectors, and the exploitation of its efficient homologous recombination 
machinery to obtain isogenic strains with specific gene deletions and other 
modifications. Due to their close phylogenetic relationship and taking advantage of 
the advances in the S. cerevisiae genetic tools, similar procedures were rapidly 
adapted and made available to K. lactis. As for all other model organisms, the 
completion of the genome sequencing project greatly enhanced the application of 
these techniques [80]. 
 
 
1.3.1. Host strain 
 
Several K. lactis strains are readily available from various sources such as DSMZ 
(www.dsmz.de), CBS (www.westerdijkinstitute.nl) and ATCC (www.atcc.org) and 
natural isolates can be obtained from a variety of dairy products [41]. For protein 
and metabolite production, the choice of the host strain, and thus the genetic 
background, is of paramount importance to achieve maximum yield. For example, 
having examined over 50 isolates, it was demonstrated that the ability of K. lactis 
to secrete recombinant human serum albumin is greatly variable in a 
strain-dependent manner [41, 69, 81]. Strain GG799, an haploid food industry 
isolate, has a track record of excellent protein synthesizing and secretory 
capabilities and is included in a commercially available expression kit (New 
England Biolabs, Massachusetts, USA). In addition, this strain presents little 
glucose repression of the β-galactosidase (KlLAC4) promoter and therefore, 
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KlLAC4-based expression is high in standard yeast growth media with glucose as 
the carbon source. 
 
 
1.3.2. Genetic tools and engineering 
 
Strain genomes can be altered by random mutagenesis followed by screening for 
a desired trait. However, oriented genetic modification of cells is often essential for 
studies and further improvement of production strains in order to achieve an 
efficient system for the overproduction of heterologous proteins. Gene deletion or 
substitution by a mutated gene, modulation of gene expression in a particular 
metabolic pathway, or controlled expression of heterologous proteins for gain of 
new functions, are also key to the improvement of strains used for metabolites 
production. An attractive feature of K. lactis as a host system is that such genetic 
modifications can be performed using a number of standard approaches and 
mutagenesis techniques. 
 
 
1.3.2.1. Selectable markers 
 
Common auxotrophic backgrounds (e.g. ura3, leu2, trp1) that are often found in 
S. cerevisiae strains have been widely used in K. lactis strains. Such markers 
permit a wide range of genetic and molecular techniques for manipulating yeast 
but it has been observed, for example in S. cerevisiae [82], that they can also have 
a detrimental effect on industrial production yields. Such effect has also been 
observed in K. lactis where introduction of a uracil auxotrophy (ura3) into a strain 
resulted in a reduced yield of a heterologous protein over 10-fold even when 
grown in the presence of exogenous uracil [38]. It is likely that cells that are 
already burdened by abundant production of a heterologous protein are further 
stressed by having to scavenge the auxotrophic nucleotide from the growth 
medium. It is also possible that a change in a regulatory interplay of connected 
pathways or mechanisms could result in the effect observed. Thus, while 
auxotrophic markers can be helpful for initial strain development and tests, 
prototrophic backgrounds are often preferred for large industrial production 
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fermentations to achieve maximum cell growth and ultimately maximum protein 
yield. The same applies to dominant markers conferring resistance to antibiotics, 
which can be extremely useful for small-scale research applications but are 
normally not practical in the industrial production setting due to high costs or 
undesirable regulatory effects of cells. Dominant bacterial selectable marker genes 
that confer resistance to the antibiotics geneticin (G418) [83] or hygromycin B 
have also been widely used in K. lactis. An interesting advance in the area of 
selectable markers is an antibiotic-free method that enables selection by 
acetamide utilization [84]. The commercial kit for heterologous protein expression 
mentioned previously is successfully making use of this strategy. 
 
 
1.3.2.2. Episomal and integrative vectors 
 
Episomal and integrative vectors have been used to direct expression of 
heterologous proteins in K. lactis and both have their inherent advantages and 
disadvantages. Currently, there are several plasmid vector systems available to 
transform K. lactis cells and the most widely used are derived from the 
pKD1-plasmid of K. lactis var. drosophilarum [15, 85]. Thus, depending on the type 
of genetic manipulation, one can choose from a variety of vectors and two 
examples of these are a useful set of cloning vectors with different selectable 
markers, including triple K. lactis / S. cerevisiae / E. coli shuttle vectors [86] and 
template vectors for PCR-based gene deletion markers [87]. The pGKL1 and 
pGKL2 linear cytoplasmic killer plasmids replicate in K. lactis but the manipulation 
of this system is difficult due to their poor stability and because these plasmids 
cannot recognize nuclear promoters, which makes them only suitable for basic 
research. Episomal vectors derived from pKD1-plasmid can provide high copy 
numbers of expression constructs but can also pose problems, especially in large 
industrial applications, due to their instability when subjected to prolonged growth 
in the absence of selection [38]. 
While several advances were made to enable broader use of plasmids in K. lactis, 
genomic integration, despite the lower copy numbers, is still preferred for industrial 
strain engineering due to their higher stability. In many cases, it is desirable to 
target the transforming DNA, such as integrative expression vectors or gene 
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deletion cassettes, to integrate at a specific chromosomal locus. A drawback of 
gene targeting by homologous recombination in K. lactis is its low efficiency, in 
contrast to the high fidelity of gene replacement in S. cerevisiae. The rate of 
off-target integration (ectopic integration) varies from organism to organism. For 
example, targeted integration into the S. cerevisiae genome is virtually 100% 
efficient, with as little as 40 base pairs of flanking homologous DNA in the 
integration cassettes. However, K. lactis has a tendency for non-homologous 
recombination, and targeted integration at many loci has often been difficult, with 
as little as 1–2% efficiency in some cases [56, 88-90] and at least 500 base pairs 
of flanking homology may be required to isolate a transformant harboring the 
desired gene replacement. To overcome this problem, a recent approach has 
been taken involving the deletion of the KlKU80 recombination gene, which 
resulted in a drastic improvement in targeted integration using DNA constructs 
having only 50–100 base pairs of homologous flanking sequences [91]. Regarding 
production of heterologous proteins, a common expression method utilizes the 
strong KlLAC4 promoter to drive gene expression and to direct insertion of the 
vector into the genome at the KlLAC4 locus [41, 53]. A variant of this method was 
applied to the most frequently used integrative expression vector, pKLAC2 (allows 
for acetamide selection in place of G418), which is provided with the K. lactis 
expression commercial kit. 
 
 
1.4. K. lactis pyrimidines pathway 
 
Studies on pyrimidines synthesis in K. lactis are scarce but it is well characterized 
in S. cerevisiae (Figure 1.2). In the first two steps of pyrimidine de novo 
biosynthesis, Ura2p (carbamoylphosphate synthetase / aspartate 
transcarbamylase) catalyses the formation of carbamoyl-aspartic acid from 
bicarbonate, ATP, glutamine and aspartic acid. Carbamoyl-aspartic acid is then 
used by Ura4p (dihydroorotase) to produce dihydroorotic acid, which subsequently 
undergoes an oxidation catalyzed by Ura1p (dihydroorotate dehydrogenase, 
DHODase) to form orotic acid. A 5-phosphoribosyl group is then added to orotic 
acid by two isoenzymes, Ura5p and Ura10p (orotate phosphoribosyltransferase) 
leading to the formation of orotidine-5’-monophosphate (OMP). Ura3p then 
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mediates the decarboxylation of OMP to uridine-5'-monophosphate (UMP), which 
is subsequently used to produce all other pyrimidines. Besides de novo 
biosynthetic pathway, yeast cells use a pyrimidines salvage pathway to recycle 
pyrimidines nucleosides and bases internalized from the culture medium or 
generated intracellularly during nucleotide turnover [92] (Figure 1.2). 
 
 
 
Figure 1.2 
 
 
Figure 1.2 Pyrimidine biosynthetic pathway. Six enzymatic steps lead to the formation of UMP (uridine-5’-
phosphate) in de novo pyrimidines biosynthesis from which all pyrimidines nucleotides are further synthesized 
(black). Pyrimidines salvage pathway rely on a set of reactions in order to reutilize pyrimidines nucleosides 
and bases, either intracellular or internalized from the culture media, which can enter the pathway directly at 
UMP or at later steps (grey). OMP, orotidine-5’-phosphate. S. cerevisiae and K. lactis genes are represented 
in brackets and bold, respectively. 
 
 
 
The enzymatic steps of this pathway are regulated by feedback inhibition and 
repression and/or attenuation of its genes. The S. cerevisiae URA2 locus encodes 
a large 240-kDa multifunctional protein that possesses the carbamylphosphate 
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synthetase (CPSase) and aspartate transcarbamylase (ATCase) activities. Both 
enzymatic subunits are feedback inhibited by UTP [93]. In addition, UTP exerts a 
repression on the URA2 transcription but negative feedback control must be 
considered to be the most effective regulatory process [94]. When uracil, a 
common and naturally occurring pyrimidines precursor, is present in the growth 
media, it is imported into the cells by a specific permease [95] and transformed 
into UMP by the enzymes of the salvage pathway [96]. This will lead to an 
increase of the UTP pool and consequently to the inhibition of de novo synthesis. 
The utilization of external uracil and related pyrimidines are therefore favored over 
the de novo biosynthesis [94]. The de novo pathway is also regulated by the weak 
transcriptional activator Ppr1p [97] that senses the levels of dihydroorotic acid and 
orotic acid [98] and upon activation under pyrimidines starvation conditions 
promotes the transcription of several URA genes [99]. 
Analysis of both S. cerevisiae and K. lactis genomes led to the identification of the 
K. lactis genes involved in the de novo pyrimidines biosynthesis [80] (Figure 1.2) 
and differences were recognized in the fourth and fifth steps. While K. lactis has 
one gene (KlURA5) coding for a orotate phosphoribosyltransferase, S. cerevisiae 
presents two isoenzymes, Ura5p and Ura10p, responsible for the formation of 
OMP, which can be explained by the genomic duplication undergone by 
S. cerevisiae [100]. The major difference concerns the step leading to the 
formation of orotic acid, which is the single redox reaction in the de novo 
pyrimidines biosynthesis pathway and is catalyzed by DHODases. S. cerevisiae 
has only one gene for a DHODase (URA1) but the presence in K. lactis of two 
genes (KlURA1 and KlURA9) coding for DHODases that belong to two distinct 
families is rather unexpected [101]. Similar to its S. cerevisiae homologue, 
KlUra1p seems to belong to the DHODase family 1A, which includes cytosolic 
enzymes that use fumarate as electron acceptor. On the other hand, KlUra9p 
seems to belong to the DHODase family 2, which includes enzymes that are 
localized in the inner mitochondrial membrane and deliver electrons to quinone 
[101, 102]. Although no functional or localization studies have been made in 
K. lactis, this suggests that its de novo pyrimidine biosynthesis pathway may be 
coupled to the mitochondrial respiratory chain via the KlUra9p DHODase. 
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1.5. Orotic acid production and applications 
 
1.5.1. Orotic acid production in microorganisms 
 
Mutants blocked in one of the last two steps of UMP biosynthesis (Figure 1.2) are 
prone to accumulate the intermediate orotic acid (Figure 1.3) and cannot grow 
unless pyrimidines or its precursors that could be salvaged, such as uracil, are 
available [103]. Several of these pyrimidine-requiring mutant microorganisms have 
been described to accumulate and secrete orotic acid. This phenomena has been 
first described in the late 40s with a pyrimidine-requiring mutant of the filamentous 
fungus Neurospora crassa [104]. Since then, the secretion and accumulation of 
orotic acid in the growth media was reported for other microorganisms bearing one 
of the pyrimidines-requiring mutation. That was the case for the bacteria 
Enterobacter aerogenes  (formerly Aerobacter aerogenes)  [105, 106],  E. coli 
[103, 107, 108], Corynebacterium glutamicum (formerly Micrococcus glutamicus) 
[109, 110] and Corynebacterium ammoniagenes (formerly Brevibacterium 
ammoniagenes) [111, 112]. A pyrimidine-requiring mutant of Candida tropicalis 
[113] and, more recently, of Candida albicans [114] were the only yeasts reported 
to accumulate orotic acid in culture media. Since similar pyrimidines-requiring 
mutants of other microorganisms do not accumulate orotic acid, other factors must 
contribute to this phenotype. For example, C. albicans Caura3∆ mutants are able
 
 
 
Figure 1.3 
 
 
Figure 1.3 Orotic acid molecule. Salts of orotic acid, orotates, can be formed by the deprotonation of the 
carboxyl group. 
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to produce orotic acid in yeast extract - peptone - glucose (YPD) media only if it is 
supplemented with acetate and S. cerevisiae ura3∆ mutants do not present 
evidences for orotic acid production in either conditions. 
The reports of orotic acid producing microorganisms encouraged studies for the 
production of this molecule mainly driven by the interest in industrial applications. 
Success has been achieved for some species of the genus Corynebacterium, in 
particular for C. glutamicum [110]. For the other microbial cells mentioned, 
concentrations of orotic acid in the media were found to range from 1 – 3 g/L and 
no commercial production was accomplished. A process for the chemical 
production of orotic acid from trichloroacetyl chloride, ketene and urea was 
patented [115] but is much less efficient regarding its costs  [116] when compared 
to the biological system described in the following section 
 
 
1.5.2. Orotic acid production using C. glutamicum 
 
C. glutamicum is an aerobic, gram-positive, nonsporulating, nonpathogenic and 
mycolic acid-containing bacterium with enormous importance in the biotechnology 
industry. Since 1957, glutamate has been industrially produced by fermentation 
using C. glutamicum and several other amino acids are now produced with this 
system. The excellent production capabilities of C. glutamicum were further 
exploited for the production of orotic acid. A first patent was issued in 1963 
describing a method for the production of orotic acid by a fermentation process 
using a pyrimidine-requiring C. glutamicum mutant (ATCC 14275) [109]. A second 
patent was granted several years later in 1991 [110]. In this patent, the original 
mutant ATCC 14275 was further optimized by screening randomly mutagenized 
cells for resistance to a pyrimidine analogue or to both a pyrimidines analogue and 
a sulfanamide drug. In result, the new mutant strains selected significantly 
increased the efficiency of orotic acid production. The composition of production 
media mentioned in the patent and the claimed concentrations of orotic acid 
obtained in flask and bioreactor cultures, are presented in Table 1.1. 
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Table 1.1 
Table 1.1 Composition of the production media (A) and orotic acid production in flask and bioreactor cultures 
(B) using pyrimidines-requiring mutants of C. glutamicum. Strains T-26, T-29 and T-30 were obtained by 
screening randomly mutagenized cells of ATCC 14275 for resistance to a pyrimidine analogue or to both a 
pyrimidines analogue and a sulfa drug. Examples of the pyrimidine analogue are 5-fluorouracil, 6-azauracil, 
2-thiouracil, 5-hydroxyuracil, and trimethoprim. Examples of the sulfanamide drug are sulfaguanidine, 
sulfathiazole, sulfapyridine and sulfamerazine. Strains resistance is the following: T-26 - 5-fluorouracil 
resistant; T-29 - 5-fluorouracil and trimethoprim resistant; T-30 - 5-fluorouracil and sulfaguanidine resistant. 
Data presented in this table originates from the patent issued in 1991 [110]. 
 
 
 
 
 
Blackstrap molasses is the dark, viscous molasses that remain at the end of the 
extraction process of sugar from raw sugarcane and it has been long used as a 
carbon source material in the biotechnology industry. The amount of sugar of the 
molasses used in the patent was not disclosed but, taking into account the 
average and common concentration found in most blackstrap molasses, its 
concentration should be about 50% sugar. Therefore, in a production media 
containing, in general, 50 mg/L of uracil to support growth, 10% sugars and 
1% urea plus 0.5% ammonium sulfate as nitrogen source, the original 
pyrimidine-requiring mutant was able to produce 8.2 g/L of orotic acid after 120 h 
in flask cultures. It is important to mention the use of 2% calcium carbonate that, 
besides acting as a pH stabilizer mainly in the flask cultures, may also serve as an 
important raw material for orotic acid production as it constitutes one of the initial 
substrate of the de novo biosynthetic pathway (Figure 1.2). The most efficient of 
the improved mutant strains (T-30) was able to generate a concentration of 
Production media 
Blackstrap molasses *    20% 
Ammonium sulfate    0.5% 
Urea      1.0% 
Potassium dihydrogenphosphate  0.05% 
Dipotassium hydrogenphosphate  0.05% 
Magnesium sulfate    0.05% 
Calcium carbonate    2.0 % 
Uracil      50mg/L 
*  500ml 50% blackstrap molasses added to bioreactor 
cultures 24h after start 
A 
Strain           Orotic Acid (g/L) 
   Batch   Bioreactor * 
   (120 hr)  (84 hr) 
ATCC 14275   8.2   28.5 
T-26    13.0   50.3 
T-29    14.0   53.2 
T-30    14.5   56.0 
B 
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14.5 g/L of orotic acid under the same conditions in flask cultures. In a 5 L 
bioreactor with 2 L of production media, the original mutant produced 28.5 g/L of 
orotic acid only after 84 h whereas the concentration reached with the T-30 mutant 
strain was 56.0 g/L. Beside the presumably fully optimized and controlled system, 
the production in the bioreactor was considerably higher when compared to the 
production in flasks also due to the addition of 500 ml of 50% blackstrap molasses 
into the production media after 24 h of growth. 
Undoubtedly, the efficiency of C. glutamicum mutants in the production of orotic 
acid is extremely relevant and for that reason those strains are the mostly used for 
its production. However, to our knowledge, the 1991 patent was the last on this 
matter, raising the question why no further significant improvements were 
achieved with this bacteria and opening the way to other microorganisms that may 
pose as a valid and more cost-effective alternative. 
 
 
1.5.3. Market application of orotic acid 
 
Mineral salts of orotic acid, orotates, have been used in industry for several 
applications. There is a lifetime study on orotate by the German physician Hans 
Nieper [117, 118] who used orotates clinically to treat thousands of patients for 
nearly every ailment imaginable. Along with its important role as precursors of 
pyrimidines nucleotides, Nieper claimed that orotate salts, being neutrally charged, 
could easily cross cell membranes, effectively delivering the minerals. 
Unfortunately, Nieper tried to explain his clinical results by invoking nonsensical 
physical theories. Consequently, his contributions to medicine were ignored by the 
medical world, and most of his medical claims were never rigorously tested. In 
recent years, a few of his orotate applications have received scientific scrutiny and 
have been found to work. Regarding its properties, the coordination chemistry of 
orotate has been studied in detail. Research in this area ranges from bioinorganic 
to pharmaceutical and materials chemistry [119, 120].  
In the pharmaceutical industry, orotate is included in a group of compounds 
considered to be “pharmaceutically acceptable carriers”. The recognition of its 
biological carrier function led to the use of orotate salts to cure syndromes 
associated with deficiency of metal ions, such as calcium, magnesium, zinc, or 
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iron [121-124]. In addition, platinum, palladium and nickel orotate complexes have 
been screened as anticancer agents [125, 126]. As an active ingredient, orotic 
acid has been associated to the treatment of heart diseases due to its 
cardioprotective effects since it was shown to improve the energy status of injured 
myocardium by stimulating, among others, the synthesis of glycogen and ATP 
[127-130]. 
The fast growing industry of nutraceutics also takes advantage of mineral salts of 
orotate and many products are easily available in the market for a wide variety of 
applications. Lithium orotate, for instance, is a highly bioavailable form of lithium 
that is available without a prescription to treat bipolar disorder. Initially based on 
Nieper studies, such products claim that lithium orotate has a higher bioavailability 
(it is 20 times more bio-active than other lithium salts, such as lithium carbonate or 
lithium citrate). Thus, lower doses of lithium orotate may be used to achieve 
therapeutic brain lithium concentrations and relatively stable serum concentrations 
while greatly reducing the likelihood and severity of potential side effects. 
Moreover, potassium and magnesium orotates are used by athletes to increase 
endurance and can be found in some mineral supplemented beverages [131]. 
Orotic acid is also known as vitamin B13. Although orotic acid is not officially 
considered a vitamin these days, over 40 years ago it was found to have 
growth-promoting, vitamin-like properties when added to the diets of laboratory 
animals. Therefore, it has been commercially used in the feed industry for that 
purpose in the composition of feed additives for ruminants and poultry [132]. 
Applications in the chemical and biotechnological industry are of major importance 
since it has been used as the starting material to produce pyrimidines, pyrimidines 
analogues and several other related molecules with higher market value [133-
135]. The most significant use of orotic acid for such purposes comes from the 
Japanese pharmaceutical and biotechnology company Kyowa Hakko Kirin Co., 
Ltd. This company is among the 40 largest in the world by revenue and was 
established after the merger of Kyowa Hakko Kogyo Co., Ltd. with Kirin Pharma 
Co., Ltd. in 2008. The patents regarding the orotic acid production by 
C. glutamicum were assigned precisely to Kyowa Hakko Kogyo Co., Ltd., which 
has been since then its leading manufacturer. They have further developed a 
strong and ingenious biotechnology to produce other valuable molecules from 
orotic acid now available from the Kyowa Hakko Bio Co., Ltd (succeeded 
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Bio-Chemical business from Kyowa Hakko Kogyo Co., Ltd). Among others is the 
artificial biosynthesis of sugar nucleotides (ABS system) and the artificial 
biosynthesis of carbohydrates (ABC system) (Figure 1.4), which are combined 
systems that have as the first step a long used biotechnology to produce 
nucleotides (UTP, GTP, CTP, etc) from orotic acid or guanosine monophosphate 
(GMP) [134]. This ABS system offers a simple and effective production process of 
sugar nucleotides and basically makes use of the combination and 
reaction coupling between C. ammoniagenes, which has a strong activity to 
produce nucleotides, and E. coli, which is metabolically engineered and expresses 
the genes of sugar nucleotide biosynthesis. For the ABC system a third step is 
combined using an engineered E. coli that possesses a specific 
glycosyltransferase gene. With this system, various complex oligosaccharide are 
synthesized directly from a specific sugar (basically corresponding to a sugar 
nucleotide) and acceptor sugar. Therefore, originally from orotic acid as a major 
substrate, the pyrimidines nucleotides, sugar nucleotides and complex 
oligosaccharides can be obtained at any step depending on the combined systems 
used. Having a significant higher market value, these compounds are mostly used 
in the pharmaceutical and other biotechnology industries. 
 
Figure 1.4 
 
 
Figure 1.4 Combined biological systems used by Kyowa Hakko Bio Co. Ltd. for the production of nucleotides, 
sugar nucleotides and complex oligosaccharides from orotic acid or guanosine monophosphate (GMP) and 
sugars. Image modified from original in www.kyowahakko-bio.co.jp. 
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1.6. Oxidative stress response in yeast 
 
Unlike S. cerevisiae, K. lactis possesses two distinct DHODases that catalyze the 
fourth step of de novo pyrimidines biosynthetic pathway. According to the 
homology with DHODases from other species, KlUra9p seems to be linked to 
respiration by delivering electrons to oxygen through the mitochondrial electron 
transport chain [101]. This raises the hypothesis of a possible connection between 
de novo pyrimidines biosynthetic pathway and oxidative stress regulation in 
K. lactis. 
The oxidative stress response in K. lactis is a mostly unexplored field. However, 
K. lactis has been proposed as a suitable model for the study of cellular responses 
to hypoxia [30] and these	   conditions are known to induce genes related to the 
oxidative stress response in S. cerevisiae [136, 137]. Several studies based on 
comparative genomics combining in silico and experimental approaches have 
been performed in K. lactis [138-140]. Regarding oxidative stress response, the 
search in the K. lactis genome of putative S. cerevisiae orthologs related to the 
oxidative stress response has suggested that pathways and proteins are generally 
conserved. The players and mechanisms involved in the oxidative response in 
S. cerevisiae have been extensively reviewed [141-143] and are briefly 
summarized in the next sections. 
 
 
1.6.1. Reactive oxygen species 
 
Oxygen is essential to all aerobic living organisms as it is used as the final electron 
acceptor in the mitochondrial respiratory chain. This is determinant for the efficient 
production of energy but, on the other hand, the reactive oxygen species (ROS) 
produced can oxidize biomolecules resulting in cellular damage. To cope with the 
toxicity of ROS, all organisms possess enzymatic and nonenzymatic antioxidant 
defenses [144-146]. Under normal physiological conditions, the primary 
antioxidant defenses, which neutralize ROS, and secondary defenses, which 
repair or degrade oxidized biomolecules, are able to regulate and maintain redox 
homeostasis and ultimately, prevent oxidative damage of the cells. An oxidative 
stress occurs when the levels of ROS exceed the antioxidant capacity of the cells. 
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Mitochondrial respiration is the major source of ROS but cells can also generate 
these oxidizing compounds from other sources [147-149]. The superoxide anion 
(•O2−) is one of the main ROS and is derived from leakage of electrons from the 
respiratory chain. Hydrogen peroxide (H2O2) is generated from several metabolic 
steps, including dismutation of •O2− by superoxide dismutases, oxidation of fatty 
acids, and from protein-folding reactions involving disulphide bond formation. A 
variety of organic hydroperoxides result from the oxidation of unsaturated lipids 
and amino acyl side chains. Of the many free radicals generated in cells, the most 
reactive is the hydroxyl radical (•OH) formed by reduction of H2O2 catalyzed by a 
transition metal ion such as Fe2+ (Fenton reaction). The simultaneous presence of 
H2O2 and a reductant (such as •O2−) capable of reducing and recycling the Fe3+ 
produced in the Fenton reaction is very detrimental because it exacerbates the 
formation of •OH. During the oxidation of unsaturated lipids, a variety of reactive 
lipid radicals are also formed [150].  
 
 
1.6.2. Oxidative damage in biomolecules 
 
ROS are toxic agents that can damage a wide variety of cellular components 
resulting in protein oxidation, lipid peroxidation, and DNA damage. Protein 
oxidation is directly promoted by ROS but can also be modified by reaction with 
products of the lipid peroxidation [151]. The thiol groups of certain amino acids are 
especially sensitive to oxidation, resulting in increasingly oxidized forms (e.g., the 
sulphydryl group of cysteine can be oxidized to sulphenic, sulphinic and sulphonic 
acid derivatives). While some oxidized forms of cysteine are reversible 
modifications, the formation of sulphonic derivatives is an irreversible process that 
cannot be repaired. ROS can also lead to protein carbonylation, which is an 
irreversible modification characterized by the formation of primary or secondary 
protein carbonyls on the side chains of certain amino acids. Protein carbonylation 
is commonly used to evaluate protein oxidation [152]. Some protein co-factors can 
also be oxidized. For example, oxidation of the iron-sulfur centers of several 
proteins result in the inactivation of enzyme and the release of iron, which by 
promoting the formation of other ROS leads to further cellular damages [153, 154]. 
Depending on the type of ROS that cells are exposed to, oxidation of proteins can 
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result in processes of fragmentation, conformational changes, aggregation, or 
inactivation of amino acids in the active center [152]. When proteins cannot be 
repaired due to irreversible modifications, they must be marked for proteolytic 
pathways [155].  
The damage to lipids consist in the oxidation of polyunsaturated fatty acid by an 
autocatalytic process triggered by the •OH [156]. Some products of lipid 
peroxidation are also highly reactive, increasing the levels of free radicals that can 
further damage other biomolecules [150]. In yeasts, lipid peroxidation is limited 
since they cannot synthesize polyunsaturated fatty acids, which are only 
integrated in the membrane when present in the growth medium.  
Amongst other effects, oxidative DNA damage can alter purine and pyrimidine 
bases as well as cleave the phosphodiester DNA backbone [157]. Base 
modification is an important class of lesions due to its lethal or mutagenic effect 
and, once oxidized, bases have to be replaced by an enzymatic system. In 
S. cerevisiae, three DNA glycosylases are involved in the excision repair of 
oxidized bases [158, 159].  
 
 
1.6.3. Oxidant defense systems 
 
Non-enzymatic defenses typically consist of small molecules that can act as free 
radical scavengers, of which glutathione (GSH) is the best-known example. GSH 
is a tripeptide (L-γ-glutamyl-cysteinyl-glycine) that acts as a radical scavenger with 
the redox-active thiol group reacting with oxidants to produce glutathione disulfide 
(GSSG). However, glutathione is predominantly present in its reduced GSH form 
in S. cerevisiae and other eukaryotes due to the constitutive action of glutathione 
reductase. Glutathione reductase is an NADPH-dependent oxidoreductase that 
converts GSSG to GSH using reducing power generated by the pentose 
phosphate pathway [160]. Glutathione is possibly the most abundant redox 
scavenging molecule in cells and, consequently, the glutathione system plays an 
important role in maintaining cellular redox homeostasis. The ratio GSSG:GSH, 
therefore provides a good indication of the redox environment of cells and most 
cell compartments [161]. 
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Cellular antioxidant defenses also include a number of protective enzymes that are 
present in different subcellular compartments and can be upregulated in response 
to oxidative stress. Several peroxidases, including catalases, glutathione 
peroxidases and peroxiredoxins, keep endogenous levels of H2O2 in the 
submicromolar range. Catalases are ubiquitous heme-containing enzymes that 
catalyze the decomposition of H2O2 to water and oxygen. S. cerevisiae has two 
catalases: the peroxisosomal catalase A, encoded by CTA1, and the cytosolic 
catalase T, encoded by CTT1 [162, 163]. CTA1 expression is coordinated with 
peroxisomal fatty acid metabolism, suggesting the main physiological role of Cta1p 
is the detoxification of H2O2 generated from fatty acid β-oxidation [164]. Ctt1p is 
thought to play a more general role as an antioxidant during exposure to oxidative 
stress, since CTT1 expression is induced by various stress conditions including 
heat, osmotic, starvation, and hydrogen peroxide stress [165]. The elimination of 
the superoxide anion is carried out by superoxide dismutase (SOD). This enzyme 
catalyzes the dismutation of superoxide anion to H2O2, which can then be reduced 
to water by catalases or peroxidases. S. cerevisiae contains a cytoplasmic 
Cu,Zn-SOD (Sod1p) and a mitochondrial matrix Mn-SOD (Sod2p), which appear 
to play distinct roles during oxidative stress conditions [166]. 
 
 
1.6.4. Regulation of the response to oxidative stress 
 
Under normal physiological conditions the cellular antioxidant defenses have a 
limited capacity to face a sudden oxidative stress. Several conditions, such as an 
increase of mitochondrial respiratory chain or exposure to environmental oxidants, 
can induce an adaptive response that is essential for cell viability [167-169]. 
S. cerevisiae cells respond to ROS by altering the expression of genes encoding 
antioxidant defenses and enzymes that repair and detoxify the resulting cellular 
damage [142]. The main transcription factors involved in the regulation of oxidative 
stress responses are Yap1p and Skn7p [170, 171] although other transcription 
factors are also implicated, such as Msn2p and Msn4p [165, 172]. In S. cerevisiae, 
adaptive concentrations of H2O2 increase the translation of several antioxidants 
and stress protective molecules. These include catalase (Ctt1p) and glutathione 
peroxidase (Gpx2p) that can reduce H2O2 directly [173]. There is also increasing 
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evidence that ROS play important regulatory functions in cell signaling and thiol 
groups are key mediators of oxidative signal transduction [174]. Signal 
transduction pathways generally involve specific protein–protein interactions and 
increasing evidence indicates that oxidizing agents can control these interactions 
by altering the redox state of available thiols in protein and low molecular weight 
compounds to bring about controlled signaling events [175-177]. 
Along with the alteration of global gene expression patterns, post-translational 
changes are also important regulators of oxidative stress response. In fact, 
metabolic changes are detected within seconds of an oxidative stress, before 
slower (within minutes) changes in gene expression are measured [178, 179]. Key 
to these metabolic changes appears to be the reprogramming of carbohydrate 
metabolism, which is essential to maintain the redox balance of the cell during 
oxidative conditions. For example, the glycolytic enzyme glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) has frequently been identified as a target 
of oxidative modification in diverse cellular systems [180]. In S. cerevisiae, a 
reduced activity of GAPDH redirects glucose equivalents to the pentose 
phosphate pathway, which is the source of cellular reducing power in the form of 
NADPH. NADPH is particularly important during exposure to oxidants, since it 
provides the reducing potential for most antioxidant and redox regulatory enzymes 
including the glutathione system. It has therefore been suggested that GAPDH 
may serve a regulatory role as a sensor of oxidative stress conditions [180] by 
shifting the NADPH/NADP+ ratio to a more reduced state [181]. 
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1.7. Scope of the thesis 
 
 
1.7.1. Pyrimidines mutants of K. lactis as orotic acid producing 
microorganisms 
 
Preliminary studies have shown that a pyrimidine-requiring mutant of K. lactis 
lacking the KlURA3 gene, which encodes the enzyme orotidine-5’-phosphate 
decarboxylase involved in the synthesis de novo of pyrimidines, was able to 
accumulate a significant amount of orotic acid crystals in YPD agar media. The 
initial goal of this work was to assess and validate the potential of the K. lactis 
mutant Klura3∆, and the similar Klura5∆ mutant, to produce orotic acid using YPD 
based media in both flask and bioreactor cultures. Supported by the concentration 
of orotic acid reached under best growth conditions we further aimed to optimize 
the production media using low cost industrial by-products, such as sugarcane 
molasse, cheese whey powder and corn steep liquor, as substrate. 
 
 
1.7.2. Relation of the de novo pyrimidines biosynthetic pathway with 
oxidative stress response in K. lactis 
 
DHODases catalyze the fourth step of de novo pyrimidines biosynthetic pathway. 
The presence in K. lactis of a DHODases that may be linked to mitochondrial 
respiration raised the hypothesis of a possible connection of de novo pyrimidines 
biosynthetic pathway with oxidative stress regulation in K. lactis. We also 
hypothesized that pyrimidines mutants of K. lactis able to produce high amounts of 
orotic acid may exhibit an elevated activity of KlUra9p that would in turn promote 
an oxidative unbalance. Thus, this work also aimed to characterize changes in the 
redox status and antioxidant defenses in the orotic acid producing mutants of 
K. lactis, as well as the mechanisms underlying the putative interplay of both 
pathways. The end goal was to obtain relevant information that could be applied in 
the first part of the work and further improve the production system. 
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2. CHAPTER II - Materials and methods 
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2.1. K. lactis strains 
 
The mutants Klura3∆, Klura5∆, Klura1∆, Klura9∆, Klura2∆, Klcta1∆ and Klctt1∆ 
were generated from K. lactis DSM 70799 (CBS 2359) wild type strain (DSMZ, 
Braunschweig, Germany). Klura3∆ mutant was used to generate Klura1∆Klura3∆, 
Klura9∆Klura3∆, Klcta1∆Klura3∆ and Klctt1∆Klura3∆ mutants. Klura1∆ and 
Klura1∆Klura3∆ mutants were used to generate, respectively, Klura1∆Klura9∆ and 
Klura1∆Klura9∆Klura3∆. Klcta1∆ and Klcta1∆Klura3∆ mutants were used to 
generate, respectively, Klcta1∆Klctt1∆ and Klcta1∆Klctt1∆Klura3∆. Full length of 
the open reading frame (ORF) of KlURA3, KlURA5, KlURA1, KlURA9, KlURA2, 
KlCTA1 and KlCTT1 genes were removed to generate the various deletion 
mutants. All primers used in this study (A1/A2 and B1/B2 sets for each gene) are 
listed in Table 2.1. Each ORF with flanking regions were amplified by PCR from 
K. lactis DSM 70799 genomic DNA using A1/A2 set of primers and then cloned 
into pGEM-T Easy (Promega, Madison, USA). A fragment of this construct 
containing only the flanking regions of each ORF was amplified by PCR using the 
B1/B2 set of primers and a PvuII/EcoRV fragment containing loxP–kanMX4–loxP 
from pUG6 (Euroscarf, Frankfurt, Germany) was ligated into the open vector. Each 
deletion cassette was then amplified with A1/A2 primers and used to transform the 
parental strain by electroporation. The mutants were selected in YPD [1 % (w/v) 
yeast extract, 2 % (w/v) bactopeptone, 2 % (w/v) glucose] supplemented with 
geneticin (200 mg/L) and correct deletion was confirmed by PCR using a set of 
primers 400 bp upstream A1/A2. Cre/loxP-mediated marker removal procedure 
[182] was used to excise KanMX4. 
 
 
2.2. Media, inoculation and growth 
 
For the orotic acid production experiments, YPD [1 % (w/v) yeast extract, 
2 % (w/v) bactopeptone, 2 % (w/v) glucose] and YPD 5% [1 % (w/v) yeast extract, 
2 % (w/v) bactopeptone, 5 % (w/v) glucose] were initially used as growth media. 
Sugarcane molasse, cheese whey powder (CWP) and corn steep liquor (CSL), 
were further evaluated as alternative substrates for orotic acid production. 
Sugarcane molasse was kindly provided by RAR - Refinarias de Açúcar Reunidas,
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Table 2.1 
Table 2.1 Primers used in this study. 
 
Primer name Sequence (5’- 3’) 
A1-Ura3 CACTGTCTCTTCCCCTTAATGA 
A2-Ura3 TGTGTGCTTGCTTCTTTTCTTATC 
B1-Ura3 GTGCAACTAATTGACGGGAGT 
B2-Ura3 CAGGAAACTTAATAGAACAAATCACA 
A1-Ura5 GCCTTATCAGGATCAGATGAAG 
A2-Ura5 CAAAGACACATCCACAAGATTTTG 
B1-Ura5 TGAACAGGTGATTAATGGCGGA 
B2-Ura5 TATCACCCTCGAATCTATCTTAAC 
A1-Ura1 CCGAATAGTATCTGTGACTAAGA 
A2-Ura1 CTACTTCTTCAGTATTAGCCTTTC 
B1-Ura1 TGTTCAGTCTTACCTTGAATGTTTAT 
B2-Ura1 TTTTTCATATAGCGGTGTTTAGTATAT 
A1-Ura9 AATATTGATTCGGCTTCTCGTGA 
A2-Ura9 TCCAACAGAATCCCAAACCCA 
B1-Ura9 AGTTGATAAAAGCAAAATACGCGG 
B2-Ura9 GCTGTTACCTAATTGAAGTAAGG 
A1-Ura2 TCCTCTAAGTCCCACCTTTGA 
A2-Ura2 ACCACATTTCAAGGCAATTCTATC 
B1-Ura2 CGGAAGTTTGTATTTTCTTAAGCG 
B2-Ura2 AGGAGCTAAACAGATTCGCGTT 
A1-Cta1 CTTAAAACCTTAAGCGGTCGCT 
A2-Cta1 AGCCACCTCTTGATAGTTGCA 
B1-Cta1 GCTTATGTGTTGAATGCTATGTTC 
B2-Cta1 GAGAATTAGCTGTGCTTTCTTTCT 
A1-Ctt1 CATTTTAGACCTCTTCACCTTACA 
A2-Ctt1 AGATCAAATGAACCAGAATCAAAATC 
B1-Ctt1 TGTAGGCAGACTGTCTTGACTT 
B2-Ctt1 GACGATATTAGGAAATTGTTCAAAGT 
 
 
 
S.A. (Portugal), and contained 49% (w/v) carbohydrates and 0.06% (w/v) protein 
[183]. CWP was kindly provided by Lactogal Produtos Alimentares, S.A. 
(Portugal), and contained 73% (w/w) lactose and 12% (w/w) proteins [184]. CSL 
was kindly provided by COPAM - Companhia Portuguesa de Amidos, S.A. 
(Portugal) and contained 7.5% (w/v) carbohydrates and 0.5% (w/v) protein [183].  
The set-up for inoculation of all cultures was as follows: a) 4 ºC stock culture – a 
YPD culture grown to 2.5 g/L d.w. was centrifuged at 3000 g for 5 min and 
ressuspended in 1/10 of the same culture medium, stored at 4 ºC and used for 
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preparing every pre-culture; this stock culture was substituted every month but 
could be used longer without any effect on the pre-culture growth behavior or 
orotic acid production; b) pre-culture – an appropriate volume from the 4ºC stock 
culture (20 µl per ml pre-culture) was used to inoculate YPD medium and cells 
were grown for 24 h at 26 ºC and 180 rpm to a biomass concentration of 4.0 g/L 
d.w.; c) culture –  irrespective of the growth parameter tested, culture medium 
composition and flask or bioreactor experiments, the equivalent to 1/10 of culture 
medium volume from the pre-culture was used for inoculation. 
Several growth conditions and media were tested in flask and bioreactor and are 
described in the results section and figure legends. Potassium phthalate and 
MOPS were obtained from Sigma-Aldrich (St. Louis, USA). Bioreactor experiments 
were performed in a Biostat B2 (Sartorius, Goettingen, Germany) equipped with 
405-DPAS-SC-K8S/200 pH probe (Mettler-Toledo, Columbus, USA) and InPro 
6800 pO2 sensor (Mettler-Toledo, Columbus, USA). Solutions used for pH 
correction were 2 M NaOH and 2 M HCl. Air supply was controlled by an 
MC-10SLPM mass flow controller (Alicat Scientific, Tucson, USA). Aeration, 
agitation, temperature and pH were automatically controlled and maintained 
constant for every culture. 
 
 
2.3. Crystals characterization 
 
Diffraction data from X-ray crystallography were collected at 293 K with a Gemini 
PX Ultra equipped with CuKα radiation (λ = 1.54184 Å). The structure was solved 
by direct methods using SHELXS-97 and refined with SHELXL-97 [185]. Carbon, 
oxygen, nitrogen and potassium atoms were refined anisotropically. Hydrogen 
atoms were refined freely with isotropic displacement parameters. The refinement 
converged to R (all data) = 5.55% and wR2 (all data) = 13.09%.  
The scanning electron microscopy with X-ray microanalysis (SEM / EDS) exam 
was performed using a high resolution scanning electron microscope with 
X-Ray Microanalysis, JEOL JSM 6301F/ Oxford INCA Energy 350. Samples were 
coated with an Au/Pd thin film, by sputtering, using the SPI Module Sputter Coater 
equipment. 
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2.4. HPLC quantification of orotic acid and glucose 
 
For orotic acid quantification, an Hitachi HPLC system was used and consisted of 
the following components: L-7100 pump, L-7250 autosampler, PCR7250 peltier 
cooling rack, L-7300 Plus column oven, L-7400 UV detector and D-7000 interface 
module. The column was a XBridge C18 (3.5 µm; 4.6 mm x 150 mm) from Waters 
(Milford, USA) and was kept at 22 ºC. Mobile phase consisted of 25 mM 
K2HPO4/KH2PO4 at pH 7.0 and flow rate was 0.5 ml/min for a total run time of 40 
min. Column effluent was monitored at 280 nm. Orotic acid standard was obtained 
from Sigma-Aldrich (St. Louis, USA). 
Glucose concentrations were determined by HPLC in a Jasco chromatograph 
equipped with refractive index (RI) detector (Jasco 830-RI) and a Chrompack 
(300 mm x 6.5 mm) column at 60 ºC, using 5 mM H2SO4 as eluent at a flow rate of 
0.5 ml/min. 
 
 
2.5. Oxidative stress resistance 
 
Cells were grown overnight in YPD medium, diluted in YPD and allowed to grow 
until early exponential phase (OD600 = 0.6; corresponds to 0.14 g/ml of dry weight) 
or later phases of growth, at 26ºC in flasks agitated at 180 rpm with a culture 
volume / flask volume ratio of 1 : 5. Cells grown to OD600 = 0.6 were exposed to 
10 mM H2O2 for 30 min under same growth conditions. Samples were taken 
before and after addition of H2O2 and briefly sonicated (10 sec, output 1, 10% duty 
cycle) to eliminate cell clumps. Cell viability was determined by standard dilution 
plate counts on YPD medium containing 1.5 % (w/v) agar and expressed as the 
percentage of the colony-forming units of treated versus untreated cells. For 
viability tests at later growth stages, cells were treated with increasing 
concentrations of H2O2 for 30 min and the same procedure was used to determine 
the concentration of H2O2 required to produce 50% cell death (LC50). 
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2.6. Oxidative stress markers 
 
Protein oxidation was determined by immunodetection of protein carbonyls, as 
previous described [186]. Control and H2O2-treated cells were centrifuged at 
5,000 rpm, and protein extracts were prepared in 50 mM potassium phosphate 
buffer (pH 7.0) containing protease inhibitors (Complete, Mini, EDTA-free Protease 
Cocktail Inhibitor Tablets; Roche Applied Science), by vigorous shaking of the cell 
suspension, in the presence of glass beads, for 5 min. Short pulses of 1 min were 
used, with 1 min intervals on ice. Protein content was estimated by the Lowry 
method, using bovine serum albumin as a standard. Protein carbonylation assays 
were performed by slot-blot analysis using rabbit IgG anti-dinitrophenyl (DNP) 
(Sigma, St. Louis, USA) at a 1 : 5,000 dilution as the primary antibody and goat 
anti-rabbit IgG-peroxidase (Sigma, St. Louis, USA) at 1 : 5,000 as the secondary 
antibody. Immunodetection was performed by chemiluminescence, with a kit from 
GE Healthcare (RPN 2109). Quantification of bands was performed by 
densitometry. 
For lipid peroxidation analysis, yeast cells were pelleted, resuspended in 20 mM 
sodium phosphate (pH 7.2) 10% (w/v) trichloroacetic acid and lysed as described 
above, prior to protein content determination. Lipid peroxidation was assayed 
using 600 µL of 1% (w/v) thiobarbituric acid, 0.05 M NaOH, 0.025% (w/v) butylated 
hydroxytoluene, 100 µL of 0.1 M EDTA, and 50 µg of total proteins. 
Malondialdehyde (MDA) concentration was determined spectrophotometrically at 
532 nm [187]. 
The oxidant-sensitive probe 2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-DA) 
was used to measure the levels of ROS [188]. Prior to H2O2 exposure, H2DCF-DA 
(10 µM) was added to the culture and incubated for 15 min to allow uptake of the 
probe. Yeast extracts were prepared as described above for the protein 
carbonylation assay, except for the buffer pH, which was pH 6.0. Samples were 
diluted to 5 µg/mL protein and fluorescence was measured using a 
spectrofluorometer set at an excitation wavelength of 504 nm and an emission 
wavelength of 524 nm. Autofluorescence was measured using unlabeled controls 
and subtracted. 
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2.7. Catalase activity and glutathione levels 
 
For the analysis of catalase activity, yeast extracts were prepared as described for 
protein carbonylation and enzyme activity was determined spectrophotometrically 
at 240 nm, following H2O2 decomposition [189]. 
For the determination of glutathione levels, yeast extracts were prepared by 
combining equal volumes of 2 M perchloric acid and a cell suspension in 100 mM 
potassium phosphate buffer (pH 7.0) 2 mM EDTA. The mixture was vigorously 
shaken in the presence of glass beads, for 5 min. Short pulses of 1 min were 
used, with 1 min intervals on ice. Cell debris was removed by centrifugation at 
5,000 rpm for 5 min. The supernatant was neutralized to pH 7.0 with 2 M KOH and 
0.3 M MOPS. Protein content was estimated as described above. For oxidized 
glutathione (GSSG) determination, the samples were treated with 2% (v/v) 
2-vinylpyridine and incubated for 1 h at 4 °C with agitation. Glutathione was 
assayed by the method of Tietze [190]. The rate of color development was 
monitored at 405 nm and the concentration was determined by reference to a 
GSSG standard added to the assay cuvette (internal standard). 
 
 
2.8. Oxygen consumption 
 
Oxygen consumption rate was measured for 7.5 × 108 cells in the culture media 
using an oxygen electrode (Oxygraph - Hansatech, Pentney, UK). Data was 
analyzed using the Oxyg32 V2.25 software (Oxygraph - Hansatech, Pentney, UK). 
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3. CHAPTER III – Results  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER III 
 
Results 
 
	  	   35	  
3.1. Orotic acid production by K. lactis mutants 
 
 
This section includes results published in the following research paper: 
 
Carvalho N, Coelho E, Gales L, Costa V, Teixeira JA, Moradas-Ferreira P 
(2016) Production of orotic acid by a Klura3∆ mutant of Kluyveromyces lactis. J 
Biosci Bioeng. 121(6):625-30 
 
 
3.1.1. K. lactis Klura3∆ and Klura5∆ mutants as orotic acid producing 
microorganisms. 
 
YPD agar plates with fully grown Klura3∆ mutant cells of K. lactis started to display 
two types of crystal structures after about 1 week at 4ºC. One type was rather 
large presenting a well-defined star-like structure (Figure 3.1A) while the other 
crystals were smaller and abundant (Figure 3.1B). X-ray crystallography analysis 
of both type of crystals demonstrated that its constituent matched the structure of 
orotate, which was present as a monohydrated salt (Figure 3.1C and Figure 3.1D). 
Orotate counter-ion was identified as potassium by SEM / EDS examination 
(Figure 3.2).  
The presence of two morphological structures is likely a result of distinct crystal 
nucleation and growth when kept at 4ºC. For the matter of simplicity, despite these 
crystals were composed of potassium orotate monohydrate, the molecule 
produced by this mutant, either in crystal structures or dissolved, will be further 
referred as orotic acid. 
This phenotype was not observed in the wild type strain or in the triple mutant 
Klura1∆Klura9∆Klura3∆, in which the step prior to the formation of orotic acid is 
interrupted along with KlURA3 deletion (Figure 1.1). Also, orotic acid was not 
detected in the medium of wild type and Klura1∆Klura9∆Klura3∆ cells grown in 
liquid cultures, in contrast to what was observed with Klura3∆ mutant, as shown in 
the following sections. These evidences demonstrated that the interruption of de 
novo pyrimidines biosynthetic pathway at the Klura3p step led to the accumulation 
of the orotic acid generated by the irreversible oxidative reaction catalyzed by the
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Figure 3.1 
 
 
Figure 3.1 Large (A) and small (B) crystal structures. Scale bars represent 1 mm. C Crystal network of 
potassium orotate monohydrate. In the center of the figure is a set of overlapping orotate molecules in the 
same disposition as the molecular structure depicted on the right. K in green, O in red, N in blue, C in black 
and H in open circles. D Molecular structure of orotic acid. 
 
 
 
Figure 3.2 
 
 
Figure 3.2 SEM / EDS examination of crystals produced by K. lactis Klura3∆. Potassium was the single 
atomic element present beside carbon, nitrogen and oxygen (hydrogen not detected by this method). 
 
 
 
DHODases (KlUra1p and KlUra9p). Due to the existence of an intermediate step 
catalyzed by orotate phosphoribosyltransferase (KlUra5p) (Figure 1.1) the mutant 
Klura5∆ was also generated and tested. This mutant exhibited a phenotype similar 
to the observed with Klura3∆ cells, producing equivalent amounts of orotic acid in 
liquid cultures under any of the conditions tested. Data presented in the following 
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section refers to Klura3∆ cells since initial experiments were performed using this 
mutant. Data from Klura5∆ cells will be shown only for selected conditions to allow 
comparison and demonstrate their similar phenotype. 
 
 
3.1.2. Production of orotic acid in flask and bioreactor using YPD based 
media 
 
To assess production yields of orotic acid by K. lactis Klura3∆ mutant, it was 
important to monitor its accumulation in liquid cultures. As the phenomenon of 
orotic acid crystal formation in agar plates was observed using the rich and 
commonly used YPD growth media, the same was considered for growth in liquid 
cultures. Growth parameters were tested in flask cultures to determine their 
influence in orotic acid production and further evaluation in a bioreactor was 
required to confirm the potential value of this K. lactis mutant strain for the 
biotechnology industry. 
 
 
3.1.2.1. Production of orotic acid in flask cultures 
 
Oxygen requirements of Klura3∆ mutant and its interference in orotic acid 
production were tested in different culture : flask volume ratio conditions using 
250 ml flat bottom flasks agitated at 180 rpm, this way providing different levels of 
culture aeration (Figure 3.3). Although the different ratios tested did not affect cell 
growth, major differences were observed in the rate of orotic acid production. 
Production rate was negatively affected below 1 : 8.3 ratio (30 ml : 250 ml) and 
was maximal with at least a 1 : 12.5 ratio (20 ml : 250 ml) that led to a 
concentration of about 2.2 g/L after 48 h. We also evaluated the production at 
higher aerations using 20 ml cultures in 250 ml baffled flasks agitated at 180 rpm 
and 250 rpm but no further improvement was observed (Figure 3.4). Therefore, 
aeration conditions for further experiments were set to 20 ml culture in 250 ml flat 
bottom flasks agitated at 180 rpm. 
The results shown in Figure 3.3 also indicate that an additional oxygenation, 
above the levels that already allow normal cell growth, is required for optimal 
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Figure 3.3 
 
 
Figure 3.3 Effect of aeration on orotic acid production and cell growth in flask cultures. Increase in aeration 
was achieved by incrementally decreasing volumes of YPD growth medium (50 ml to 10 ml) in flat bottom 250 
ml flasks agitated at 180 rpm. Growth was performed at 26ºC. 
 
 
 
Figure 3.4 
 
 
Figure 3.4 Effect of strong aeration / agitation on orotic acid production in flask cultures. Growth performed at 
26ºC using 20ml YPD in 250ml flasks. Increase in aeration was achieved by changing flat bottom flasks to 
baffled flasks and from an agitation of 180 rpm to 250 rpm. 
 
 
 
production rate. This is consistent with the presence of a putative mitochondrial 
Klura9p that links pyrimidines pathway to the respiratory chain and, in contrast to 
the other DHODase KlUra1p, is most likely playing a major role in the enzymatic 
step leading to the formation of orotic acid. This hypothesis was confirmed by the 
analysis of orotic acid production in the double mutants Klura1∆Klura3∆ and 
Klura9∆Klura3∆. These mutants exhibited similar growth rates but, whereas orotic 
acid production was similar using Klura3∆ and Klura1∆Klura3∆ mutants, it was 
strongly and negatively affected using Klura9∆Klura3∆ mutant (Figure 3.5). This 
mutant was only able to produce 0.7 g/L of orotic acid after 48 h. Therefore, 
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oxygen seems to be directly linked to orotic acid production due to the 
predominant or more efficient activity of KlUra9p DHODase. 
 
 
 
Figure 3.5 
 
 
Figure 3.5 Orotic acid production and cell growth of K. lactis Klura1∆Klura3∆ (circle) and Klura9∆Klura3∆ 
(square). Growth performed at 26ºC using 20ml YPD in 250 ml flat bottom flasks at 180 rpm. 
 
 
 
Using the aeration conditions already defined, different growth temperatures from 
24 ºC to 32 ºC were tested (Figure 3.6). Although cell growth was lower at 24 ºC 
and 32 ºC, orotic acid production at 24 ºC was only delayed during the early stage, 
while at 32 ºC the maximum amount of orotic acid produced was decreased. At 
24 ºC specific productivity was therefore higher than at temperatures from 26 ºC to 
30 ºC. The lower biomass and orotic acid production at 32 ºC is probably 
associated with temperature sensitivity of Klura3∆ mutant at a particular growth 
stage (after 12 h) or with deviation of energy or resources (glucose or other 
nutrients) to other mechanisms or metabolic pathways required for growth at this 
temperature. Since the best results were obtained at 26 ºC - 30 ºC with minor 
differences in both growth and orotic acid production, 28 ºC was chosen as the 
growth temperature for further optimization. 
Under these best conditions, the initial pH (ipH) of the culture medium dropped 
from 6.6 (pH of YPD medium) to 4.4 during the first 36 h and then remained rather 
constant (Figure 3.7). To evaluate the effects of pH in the production process, 
different buffering systems were tested. For these experiments, glucose 
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Figure 3.6 
 
 
Figure 3.6 Effect of temperature on orotic acid production and growth in flask cultures. Cells in 20 ml YPD 
were grown at different temperatures (24 ºC to 32 ºC) in 250 ml flat bottom flasks agitated at 180 rpm. 
 
 
 
Figure 3.7 
 
 
Figure 3.7 pH behavior of cultures grown at 28ºC using 20ml YPD in 250 ml flat bottom flasks at 180 rpm. 
 
 
 
concentration was increased from the 20 g/L used in standard YPD to 50 g/L 
(YPD 5% glucose) not only to show that the culture media could be improved and 
a glucose increment alone was sufficient to significantly increase orotic acid 
production but also because it would better demonstrate the efficacy of the 
buffering system under conditions of stronger acidification. Data regarding pH 
behavior of the cultures and its effect on orotic acid production and cell growth are 
summarized in Figure 3.8. Cells grown in unbuffered YPD 5% glucose with an 
ipH 6.6 as in previous experiments, produced 2.9 g/L after 48 h and 3.9 g/L after 
72 h and culture pH dropped from 6.6 to 3.4. Optimum pH for growth of K. lactis 
wild type strains is known to be 4.5 - 5.0 and for that reason phthalate (pKa 5.5) 
was used to buffer the cultures and maintain pH values close to that range. The 
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concentration of phthalate used (75 mM) did not affect the growth of Klura3∆ cells 
and was sufficient to prevent a drop over one pH value from an ipHs of 5.5. 
However, stabilizing pH with phthalate for most of the culture period at about 4.7 
did not improve orotic acid production. 
 
 
 
Figure 3.8 
 
 
Figure 3.8 pH behavior of unbuffered and buffered cultures and its effect on orotic acid production and growth 
in flask cultures. 75 mM phthalate at ipH 5.5 and 200 mM MOPS at ipH 7.0, 7.5 and 8.0 were used to stabilize 
culture pH above the values obtained with unbuffered cultures at ipH 6.6 and 8.0. Growth was performed 
using 20 ml YPD 5 % glucose in 250 ml flat bottom flasks at 28 ºC and 180 rpm. 
 
 
 
To test orotic acid production in cultures with pH stabilized at higher values, MOPS 
buffer (pKa 7.2) was used. MOPS has lower buffering capacity than phthalate and 
a concentration of 200 mM was required to prevent a drop of pH higher than 1 -1.5 
in the cultures tested without having a negative effect on growth (Figure 3.8). In 
fact, some increase in final biomass was observed in cultures buffered with 
MOPS. Under these conditions, orotic acid concentration far exceeded its solubility 
(1.8 g/L in water at 18 ºC) and microscopic spike like crystals were already visible 
at 48 h. Therefore, for orotic acid quantification, concentrated NaOH was added to 
a final concentration of 250 mM to dissolve orotic acid crystals in the samples 
(solubility in 1 M NaOH is 50 g/L). The results shown in Figure 3.8 clearly show 
that stabilizing culture pH with MOPS at values closer to 7 strongly increased 
orotic acid production. Both unbuffered cultures with ipH 6.6 and ipH 8.0 acidified 
to pHs below 4. On the other hand, MOPS cultures that started at ipH 8.0 
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maintained its pH close to 7. Whereas unbuffered cultures only produced about 
3.9 g/L after 72 h without significant increase up to 96 h, MOPS cultures with 
ipH 8.0 were able to produce 5.6 g/L after 72 h and 6.7 g/L after 96 h. Culture pH 
is therefore critical for orotic acid production and, due to the strong tendency of the 
culture to acidify, the use of this buffer system is essential to sustain pH at optimal 
values. It was not possible to test orotic acid production in buffered cultures with 
pH stabilized at even higher values, either with MOPS or other buffer with higher 
pKa, since ipH of the culture would necessarily have to be increased and cell 
growth is affected above pH 8. Nevertheless, taking into account the differences 
observed between MOPS cultures at ipH 8.0 and ipH 7.5, a significant 
improvement in production would not be expected if pH could be stabilized above 
7.0. Moreover, as shown in the following section, maintaining culture pH at 8.0 in a 
bioreactor had a negative effect on the production. 
The results obtained from cultures buffered with phthalate and MOPS 
demonstrated that Klura3∆ cells can grow well at any pH from about 4.5 to 7 and 
that pH 7 is probably the most favorable for specific mechanisms involved in the 
production and/or secretion of orotic acid. With respect to glucose concentration, 
we observed that the increase of orotic acid production was only relevant if 
glucose was increased up to 50 g/L. In a buffered culture at ipH 8.0, an additional 
25 g/L of glucose (YPD 7.5% glucose) only generated a 0.6 g/L increment of orotic 
acid (Figure 3.9). In conclusion, under the conditions tested, 200 mM MOPS in 
YPD 5% glucose with ipH 8.0 was considered as the most adequate buffering 
system for orotic acid production in flask cultures. 
Available data on orotic acid producing strains with industrial value [110] show that 
a similar mutant of C. glutamicum (ATCC 14275), with pyrimidines pathway 
interrupted and no further genetic optimization, is able to produce in flask cultures 
8.2 g/L of orotic acid after 120 h (Table 1.1). However, this production was 
achieved using optimized and cheap industrial media. Having reached an orotic 
acid concentration of 6.7 g/L at 96 h in flasks, our results demonstrated the high 
potential of K. lactis Klura3∆ as an orotic acid producing microorganism. They 
strongly suggest that with an optimized industrial media and an additional 24 h 
production time, final amounts of orotic acid above 8.2 g/L could be reached at 
120 h. 
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Figure 3.9 
 
 
Figure 3.9 Orotic acid production in buffered YPD based media with glucose concentration from 2 % to 7.5 %. 
Cultures started at ipH 8.0 and were buffered with 200 mM MOPS. Growth performed at 28ºC using 20 ml 
growth media in 250 ml flat bottom flasks at 180 rpm. 
 
 
 
3.1.2.2. Production of orotic acid in bioreactor 
 
To further assess the potential of K. lactis Klura3∆ strain for the biotechnology 
industry, the production process was tested in a bioreactor system. Using the 
information obtained from flask experiments and YPD 5% glucose as production 
medium (1 L), several conditions of agitation / aeration, pH and temperature were 
tested in a 2 L bioreactor (Figure 3.10). As for flask cultures with MOPS buffer, 
NaOH was added to all samples removed from cultures after 24 h to dissolve 
orotic acid crystals and allow its quantification by HPLC. 
All results obtained in flask cultures regarding optimum conditions for orotic acid 
production were confirmed in the bioreactor. First, with temperature and pH 
maintained constant at 28 ºC and pH 7.0, a minimum aeration / agitation (500 rpm 
/ 1 vvm) above the one required for optimal growth of this mutant strain, is 
essential and sufficient for best orotic acid production rate and yield 
(Figure 3.10A). For each aeration conditions we observed that pO2 dropped to 
about 80% (800 rpm / 2 vvm), 40% (500 rpm / 1 vvm) and 10% (400 rpm / 1 vvm) 
[data not shown], thus indicating culture pO2 should not drop below 40%. Second, 
at pH 7.0 and optimum aeration / agitation conditions, orotic acid production was 
higher at 26 ºC and 28 ºC, being significantly affected at 30 ºC (Figure 3.10B). 
Third, at 28 ºC and optimum aeration / agitation conditions, best orotic acid 
production was obtained at neutral pH (Figure 3.10C) indicating that optimum pH 
	  	   44	  
for orotic acid production would be very close or at pH 7.0. Regarding glucose 
consumption, despite a minor difference observed at 30 ºC (Figure 3.10B), the 
results were similar for all other conditions tested (Figure 3.10A and 3.10C). 
Strikingly, the Klura3∆ mutant strain was still able to accumulate in the growth 
media large amounts of orotic acid after glucose has been depleted. Also, 
differences in orotic acid production under the different conditions tested were 
mostly observed after that point. 
 
 
 
Figure 3.10 
 
 
Figure 3.10 Effect of agitation (rpm) / aeration (vvm) (A), temperature (B) and pH (C) on orotic acid 
production, growth and glucose consumption in bioreactor cultures. For each set of experiments the following 
conditions were maintained constant: A - temperature and pH respectively at 28.0 ºC and pH 7.0; B - agitation, 
aeration and pH respectively at 500 rpm, 1 vvm and pH 7.0; C - agitation, aeration and temperature 
respectively at 500 rpm, 1 vvm and 28.0 ºC. 
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Production in bioreactor was optimal with growth parameters set to 28 ºC, 
500 rpm, 1 vvm and pH 7.0 and the amount of orotic acid obtained after 96 h was 
6.7 g/L (Figure 3.10A-C). Analyzing these results together with the production 
obtained in flasks under the optimized conditions already defined, it is evident that 
the rates of production are similar and the same maximum amount of orotic acid is 
reached at 96 h (Figure 3.11). Using same flask and bioreactor optimized 
conditions, it is clear that similar production was obtained with Klura5∆ mutant 
(Figure 3.11). Equivalent orotic acid production from Klura3∆ and Klura5∆ mutants 
is most likely due to a limiting phosphoribosyl pyrophosphate (PRPP) availability 
(Figure 1.1) that, together with the reversible nature of the enzymatic step 
catalyzed by KlUra5p, favors orotic acid accumulation upon KlURA3 deletion. This 
can be further favored considering the possibility that transport across the 
membrane is only possible for orotic acid and not for OMP. However, none of 
these hypotheses have been experimentally confirmed. 
 
 
 
Figure 3.11 
 
 
Figure 3.11 Orotic acid production under best conditions obtained for flask and bioreactor cultures using K. 
lactis Klura3∆ and K. lactis Klura5∆.  Flask production performed at 28ºC and 180 rpm in 250 ml flat bottom 
flasks with 20 ml YPD 5% glucose media with ipH 8.0 containing 200mM MOPS. Bioreactor production 
performed at 28 ºC, 500 rpm, 1 vvm and pH 7.0 in YPD 5% glucose media. 
 
 
 
The high reproducibility of orotic acid production in flask and bioreactor is very 
relevant regarding experimental optimization of the industrial production process. It 
is not uncommon to encounter biological systems that behave considerably 
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different after scaling up production to a bioreactor. Inversely, flask systems are 
often not able to provide full optimum conditions, which can only be achieved in a 
highly controlled bioreactor system. In this case, experimental results obtained in 
flasks regarding industrial media optimization or K. lactis mutants screening, are 
expected to be replicated in bioreactor at any stage of the development process. 
 
 
3.1.3. Assessment of production using low cost industrial media 
 
Production of orotic acid by K. lactis Klura3∆ or Klura5∆ cells using YPD based 
media would not be used in industry due to its costs. Thus, full media optimization 
should be performed using available and cheap media containing nutrients 
identified as relevant for orotic acid production. For that purpose, sugarcane 
molasse, cheese whey powder (CWP) and corn steep liquor (CSL) were evaluated 
as cheap nutrient sources. Sugarcane molasse is a concentrated by-product of the 
manufacture or refining of sucrose from sugar cane, CWP is the dried and 
concentrated form of the liquid cheese whey that is generated as a waste stream 
from cheese production facilities and CSL is a liquid by-product of wet milling 
process of maize-starch industry. Due to their high sugars content they have been 
used in various biotechnological applications as a carbon source. The sugar 
content of the raw materials obtained was 49% (w/v), 73% (w/w), and 7.5% (w/v) 
for molasse, CWP and CSL, respectively. 
The orotic acid producing mutant chosen for these tests was again Klura3∆, and 
its ability to grow solely on molasse, CWP or CSL, was assessed. Even though the 
types of sugars present in each industrial growth media were different they could 
all be metabolized by K. lactis. Hence, the initial criteria used for comparison of the 
performance of each industrial media, as well as with previous YPD media, was 
their total sugar content. The appropriate amount of each raw material was used to 
obtain a growth media with final sugar content of 20 g/L, as in regular 
YPD (2% glucose). Initial pH of each medium solution was set to 6.5 and no buffer 
was used to stabilize pH. With respect to molasse and CWP, a minor growth was 
observed only when uracil was added to a concentration normally used for growth 
of ura3 auxotrophic yeast mutants in minimal media (50 mg/L) but orotic acid was 
not detected (Figure 3.12). This indicates that, despite sugar availability, these 
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media alone do not provide all sufficient nutrients for the growth of K. lactis 
Klura3∆. Supplementation of uracil is essential and, among others, addition of a 
suitable nitrogen source would most certainly allow better growth. On the other 
hand, CSL alone was not only sufficient to allow growth but significantly surpassed 
the rich YPD media, considering both had the same amount of sugars (Figure 
3.12). More importantly, there was production of orotic acid. The lower amount 
obtained (0.33 g/L) when compared to YPD suggests that under these conditions 
its production was not significantly promoted or was subject to strong inhibition.  
 
 
 
Figure 3.12 
 
 
Figure 3.12 Orotic acid and biomass production using cheap industrial media. Each media was prepared from 
industrial raw material to allow a final sugar concentration of 20 g/L. Concentration of raw material was as 
followed: molasse - 4% (v/v); CWP - 2.75% (w/v); CSL - 26.7% (v/v). Uracil concentration used was 50 mg/ml. 
Initial pH was 6.5 and growth was performed at 28ºC using 20 ml media in 250 ml flat bottom flasks at 
180 rpm. 
 
 
 
Analysis of data from Figure 3.13 suggests that an inhibitory effect is indeed 
interfering with the production of orotic acid by K. lactis Klura3∆ in CSL. 
Decreasing the concentration of CSL from 26.7% (v/v) to 6% (v/v), corresponding 
respectively to a concentration of sugars from 2% (w/v) to 0.45% (w/v), cell growth 
decreased and less biomass was produced. However, not only the final amount of 
orotic acid reached was incrementally higher but also the rate and onset of 
production was improved. With 4% (v/v) CSL, the rate of production was further 
improved but the final amount of orotic acid produced was lower, probably as a 
consequence of less nutrients available when compared to 6% (v/v) CSL. Cell 
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growth at 2% (v/v) CSL was minor and consequently the level of production was 
very low.  
 
 
 
Figure 3.13	  
 
 
Figure 3.13 Orotic acid and biomass production using different concentrations of CSL. Concentration of raw 
CSL (v/v) is depicted for each symbol followed by the resulting sugar concentration (w/v). Initial pH was 6.5 
and growth was performed at 28ºC using 20 ml media in 250 ml flat bottom flasks at 180 rpm. 
 
 
 
The growth observed by the pyrimidines-requiring Klura3∆ mutant in CSL supports 
the idea that it is probably rich in uracil and derivatives, which are internalized and 
used by the pyrimidines salvage pathway. Those uracil concentrations most 
certainly led to the inhibition of orotic acid production as a result of the natural 
system involved in the regulation of de novo pyrimidines biosynthetic pathway in 
K. lactis. A concentration of 4-6% (v/v) seems to be optimum regarding orotic acid 
production as a result of the levels of inhibition versus cell growth achieved.  
The potential of CSL as a raw material for orotic acid production by K. lactis 
Klura3∆ is extremely significant. Its nutritional value as a cheap supplement to 
other raw materials, such as molasse and CWP, should be considered assuming it 
could provide all the remaining necessary nutrients for an optimal cell growth with 
minimal effect on the inhibition of orotic acid production. Thus, production media 
containing CSL and molasse or CWP with a combined concentration of 2% (w/v) 
sugars were tested (Figure 3.14). In both media, an increment of CSL up to 
12% (v/v) always led to an increase in biomass production and its supplementation 
to molasse resulted in a slightly better growth when compared to CWP. Regarding 
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Figure 3.14	  
 
 
Figure 3.14 Orotic acid and biomass production using CSL + Molasse (A) and CSL + CWP (B) as production 
media. Concentration of raw CSL (v/v), Molasse (Mol.; (v/v)) and CWP (w/v) is depicted for each symbol 
followed by the respective sugar concentration, which resulted in 2% (w/v) for all media. Initial pH was 6.5 and 
growth was performed at 28ºC using 20 ml media in 250 ml flat bottom flasks at 180 rpm. 
 
 
 
orotic acid production, optimal concentration of CSL for each combined media 
(Figure 3.14) fall within a range [4 – 8% (v/v)] similar to the one already observed 
when CSL was used as the sole nutrient source (Figure 3.13). However, orotic 
acid production was better when CSL was supplemented to molasse. Whereas a 
concentration of 2.2 g/L of orotic acid was achieved with 4% (v/v) CSL + 
3.4% (v/v) molasse, a maximum amount close to 1.8 g/L was obtained in the CWP 
media supplemented with 4, 6 or 8% (v/v) CSL. Actually, having the same amount 
of sugars, orotic acid production with CSL + CWP was always lower than with CSL 
+ molasse when comparing media with same CSL concentrations. The possibility 
that CWP contains higher amounts of uracil and derivatives than molasse, which 
would add to the effect already induced by CSL, is not supported by the fact that 
addition of uracil to CWP induced higher growth than molasse (Figure 3.12). The 
difference observed could simply be the result of less overall nutritive value of 
CSL + CWP after the adjustment of both combined media with respect to sugar 
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content. The types of sugar that are present in molasse and CWP may also play a 
significant role in the difference observed. Due to the distinctive advantage of 
K. lactis to utilize lactose, the use of CWP should not be completely discarded. It 
should always be accounted as a potential substitute of molasse and market 
availability together with costs of CWP compared to molasses should be evaluated 
for the validation of the production system for full scale-up. However, taking these 
results into consideration, a production media containing molasse and CSL was 
chosen for further tests. Under similar growth conditions and amount of 
sugar (2% (w/v)), orotic acid production with cheap media composed by 4% (v/v) 
CSL and 3.4% (v/v) molasse (Figure 3.14A) was the same 2.2 g/L obtained with 
the rich and expensive YPD media (Figure 3.6; 28ºC). 
 
 
 
Figure 3.15 
 
 
Figure 3.15 Effect of pH on orotic acid production and growth using CSL and CSL + Molasse media. 
Concentration of raw CSL (v/v) and Molasse (Mol.; v/v) is depicted for each symbol followed by the resulting 
sugar concentration (w/v). Initial pH of the cultures: unbuffered – ipH 6.5; buffered CSL – ipH 7; CSL + 
Molasse – ipH 8. Growth was performed at 28ºC using 20 ml media in 250 ml flat bottom flasks at 180 rpm. 
 
 
 
Culture pH in CSL containing media (6% CSL (v/v) or 4% (v/v) CSL + 3.4% (v/v) 
molasse) did not show the behavior previously observed for YPD unbuffered 
cultures (Figure 3.15). In unbuffered 6% (v/v) CSL cultures, the pH dropped 
initially as in YPD but, instead of staying at acidic pH for the remaining culture 
period, it increased considerably up to pH 8.8. A rather delayed but similar pH 
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behavior was observed in the unbuffered culture containing 4% (v/v) CSL + 
3.4% (v/v) molasse. CSL appears to be the inducing factor of such effect in the 
combined media as well but the underlying K. lactis Klura3∆ metabolic 
mechanisms and CSL constituents involved in this behavior were not determined. 
To test pH stabilization of these cultures at neutral values, MOPS buffer was 
added to a concentration of 200mM MOPS. An ipH 7 was sufficient to maintain 
culture pH close to 7 in buffered 6% (v/v) CSL culture whereas an ipH 8 was 
required for the cultures containing 4% (v/v) CSL + 3.4% (v/v) molasse. As 
observed for YPD buffered cultures, pH stabilization at values close to pH 7 
increased orotic acid production (Figure 3.15). A more marked positive effect was 
observed for the culture containing CSL alone, since the final amount of orotic acid 
produced was higher and the onset of production was significantly reduced. For 
the culture containing CSL and molasse, beside an increased final amount of 
orotic acid obtained, pH stabilization at pH 7 also resulted in a positive effect on 
the rate of production. 
 
 
Table 3.1 
Table 3.1 Orotic acid production after 80 h using 4% (v/v) CSL+ 3.4% (v/v) Molasse production media 
supplemented with molasse (Mol.), and therefore sugars, nitrogen sources ((NH4)2SO4 or urea), phosphate 
(K2HPO4) or magnesium (MgSO4). Each culture contained 200mM MOPS for pH stabilization and ipH was set 
to 8. Growth was performed at 28ºC using 20ml media in 250 ml flat bottom flasks at 180 rpm. 
 
Orotic acid production after 80 h (g/L) 
4% (v/v) CSL + 3.4% (v/v) Molasse 
+ 
Ø 
+ 
3.4% (v/v) Mol.  
+ 
0.25% (NH4)2SO4 
+ 
0.25% Urea 
+ 
0.05% KH2PO4 
+ 
0.025% MgSO4 
 
2.4 
 
2.6 
 
3.5 
 
4.5 
 
2.5 
 
2.5 
 
 
 
Using the buffered 4% (v/v) CSL + 3.4% (v/v) molasse media as the minimal 
composition, we incremented the carbon source (molasse) or added defined 
sources of nitrogen ((NH4)2SO4 and urea), phosphate (KH2PO4) and magnesium 
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(MgSO4) (Table 3.1). Besides the carbon source, the compounds (NH4)2SO4, 
KH2PO4 and MgSO4 are the major and most common constituents used for yeast 
growth in minimal synthetic media. Urea is often used as a complement or 
alternative to (NH4)2SO4 as nitrogen source. After 80 h growth it was clear that the 
addition of sugar (molasse) did not improve orotic acid production. This was likely 
due to the fact that nitrogen sources were a limiting factor, as the supplementation 
of (NH4)2SO4 or urea resulted in an improvement of final amount of orotic acid 
produced. It is evident that the composition of the production media can be further 
and significantly improved by optimizing the amount and ratio of molasse versus 
nitrogen source. The increase in orotic acid production was considerably higher 
when urea was used as nitrogen source, indicating that it should be considered as 
the best option for that purpose. Addition of phosphate and magnesium did not 
improve production suggesting that at these production levels CSL is providing 
sufficient amounts of these elements. Flask cultures of K. lactis Klura3∆ grown in a 
buffered production media containing 4% (v/v) CSL, 3.4% (v/v) molasse and 
0.25% (w/v) urea, which provided 2% (w/v) sugars, were able to produce 4.5 g/L of 
orotic acid after 80 h. For the same culture time, the production in buffered YPD 
(2% glucose) under similar growth conditions was shown to be 3.4 g/L 
(Figure 3.9). This indicates that the cheap production media described can provide 
better results regarding orotic acid production. 
The production of 4.5 g/L of orotic acid after 80 h by K. lactis Klura3∆ with 
industrial production media is still far from the 8.2 g/L obtained after 120 h in flask 
cultures with the original ATCC 14275 C. glutamicum mutant strain. However, 
when the production media used with C. glutamicum (Table 1.1) is compared with 
the one we used, the yield obtained with K. lactis is higher than C. glutamicum and 
the potential of production improvement is convincingly strong. The production 
media used by C. glutamicum contained the same type of molasses used in this 
work but it was not disclosed the amount of sugars. Assuming sugar content of 
those molasses used would be 50% (w/v) (average found in molasses), final 
amount of sugars in the production media would be 10% (w/v). Using the amount 
of sugar to compare the yield of the orotic acid obtained by both production media 
we verify that C. glutamicum mutant required 100 g/L of sugars to achieve 8.2 g/L 
of orotic acid whereas Klura3∆ produced 4.5 g/L with only a combined 20 g/L of 
sugars. The productivity of Klura3∆ (0.225) is almost 3 times higher than the one 
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obtained for C. glutamicum mutant (0.082). As observed on the flask studies of 
buffered YPD based media an increment in glucose could improve orotic acid 
production since its composition must provide other required nutrients in excess. 
An increment from 2% glucose used in regular YPD to 5% led to an increase of 
orotic acid from 3.6 g/L to 6.7 g/L (Figure 3.9). Taking all together, the final amount 
obtained and yield of orotic acid production at this stage is already promising and 
further optimization of the production media would certainly allow higher 
production levels. 
The knowledge obtained from the tests on the production media base on cheap 
industrial by-products should next be used in the development of experimental 
matrixes to determine best combinatorial composition of these constituents and to 
identify other nutrient requirements at higher production levels of orotic acid. 
However, the inhibition of production by CSL constituents should be first 
addressed to confirm it results from the action of uracil but mostly, to evaluate the 
possibility of reducing or even eliminate such effect. In that case, the amount of 
CSL used in the production media could be increased, which would significantly 
alter the characteristics of the media, and therefore, its development strategy. 
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3.2. Relation of the de novo pyrimidines biosynthetic pathway with 
oxidative stress response in K. lactis. 
 
 
3.2.1. Studies at early exponential phase 
 
The de novo pyrimidine biosynthetic pathway includes a redox step catalyzed by 
DHODases, including in K. lactis a KlUra9p possibly localized in mitochondria 
[101]. Redox homeostasis and mitochondrial function are critical for oxidative 
stress resistance. This led us to assess the role of the pyrimidine pathway in H2O2 
resistance, using wild type (WT) cells and mutants with the pathway interrupted at 
distinct steps, namely Klura1∆Klura9∆ (lacks both DHODases), Klura5∆ and 
Klura3∆ cells. Cells were grown overnight in YPD to early exponential phase 
(OD600 = 0.6) and then exposed to 10 mM H2O2 for 30 min. Under these 
conditions, the viability of WT cells was 27% but decreased to 14% in Klura3∆ 
mutants (Figure 3.16). However, the viability of mutants with the pyrimidines 
pathway interrupted in the previous steps, Klura5∆ and Klura1∆Klura9∆, was 
similar to the observed in the WT strain. At this stage of cell growth, it is not 
expected a fully active de novo synthesis of pyrimidines since YPD media 
pyrimidines derivatives and salvage pathway are most likely providing sufficient 
 
 
 
Figure 3.16 
 
  
Figure 3.16 Oxidative stress resistance of K. lactis WT, Klura1∆Klura9∆, Klura5∆ and Klura3∆ cells. Cells 
were grown in YPD to OD600 = 0.6  and exposed to 10 mM H2O2 for 30 min. Cell viability was determined as 
described in methods. Values are mean ± SD of at least three independent experiments. 
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pyrimidines to the pathway and inhibiting synthesis de novo. This could explain the 
similar phenotypes of WT, Klura1∆Klura9∆ and Klura5∆ cells but not the reduced 
viability of Klura3∆ mutants. In addition, since both Klura5∆ and Klura3∆ cells have 
the pathway interrupted in steps following the redox reaction catalyzed by 
DHODases, it was expected that these mutants would have similar phenotypes. 
However, the deletion of the KlURA3 but not of the KlURA5 gene decreased the 
ability of the cells to cope with a similar external oxidative stress. 
Several biomarkers for oxidative damage and oxidative stress response were then 
evaluated in WT and Klura3∆ cells before and after exposure to H2O2 
(Figure 3.17). No differences were observed in protein carbonylation, lipid 
peroxidation and ROS levels, suggesting that WT and Klura3∆ cells are subjected 
to identical levels of oxidative damage. The analysis of oxidative stress defenses 
revealed that KlURA3 deletion did not affect catalase activity or total glutathione 
levels. However, H2O2-induced glutathione oxidation was lower in Klura3∆ cells, 
despite the higher sensitivity of this mutant to H2O2. 
The oxidative nature of the DHODase reaction in the de novo pyrimidines 
biosynthesis urged us to investigate the potential role of this enzymatic step in 
Klura3∆ phenotype. The K. lactis mutants Klura1∆Klura3∆ and Klura9∆Klura3∆, 
previously generated to demonstrate that the mitochondrial KlUra9p is more 
relevant to the pathway than KlUra1p under higher aerations conditions 
(Figure 3.5), were used in this study. Mutants bearing the single deletion of each 
of the DHODase genes were also produced (Klura1∆ and Klura9∆) and analyzed 
together with the double mutants. Cell viability after H2O2 exposure was 
determined on these mutants, and remarkably, clear differences to WT and 
Klura3∆ were observed (Figure 3.18). Both Klura1∆ and Klura9∆ mutants had a 
significant decrease in viability compared to WT or the double mutant 
Klura1∆Klura9∆ (see Figure 3.16) despite a more pronounced effect on Klura1∆. 
The viability of this last mutant was even inferior to the one observed for Klura3∆ 
but similar in the case of Klura9∆. On the other hand, in Klura1∆Klura3∆ and 
Klura9∆Klura3∆ mutants, the viability significantly increased to levels even 
superior to WT or Klura1∆Klura9∆. Opposite to the single mutants Klura1∆ and 
Klura9, the double mutant Klura1∆Klura3∆ showed a more pronounced effect than 
Klura9∆Klura3∆. It is not possible to correlate the results of these mutants and 
explain the phenotypes observed based solely on the viability tests outcome.
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Figure 3.17 
 
 
Figure 3.17 Assessment of oxidative stress markers and antioxidant defenses in WT and Klura3∆ cells. Cells 
were grown in YPD to OD600 = 0.6  and exposed to 10 mM H2O2 for 30 min. For evaluation of oxidative stress 
markers, the levels of protein carbonylation (A), lipid peroxidation (B) and ROS (C) were measured. Values for 
protein carbonylation are expressed as % of untreated WT. The antioxidant defenses measured were catalase 
activity (D) and total (E) and oxidized (F) glutathione levels. Values are mean ± SD of at least three 
independent experiments. 
 
 
 
Even so, it is evident that at this growth stage and under these conditions a) the 
deletion of the KlURA3 induces a distinct phenotype characterized by an 
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increased sensibility to H2O2 that was not observed in WT or other mutants with 
the pathway interrupted at the two earlier steps; b) even with the presence of the 
gene that codes for the other DHODase, independent deletion of KlURA1 or 
KlURA9 promotes a phenotype similar to Klura3∆ whereas double DHODase 
deletion (Klura1∆Klura9∆) shows no difference to WT; c) an obvious relation exists 
between the deletion of KlURA1 or KlURA9 along with KlURA3 since the 
phenotypes of any of these individual mutants are reversed and a significant 
increase in the resistance to H2O2 is observed above WT values. In conclusion, 
these results suggest an interrelationship, which requires the three genes KlURA1, 
KlURA9 and KlURA3, that may be involved in oxidative stress mechanisms or 
regulation. 
 
 
 
Figure 3.18 
 
 
Figure 3.18 Oxidative stress resistance of K. lactis Klura1∆, Klura9∆, Klura1∆Klura3∆ e Klura9∆Klura3∆ cells. 
Cells were grown in YPD to OD600 = 0.6  and exposed to 10 mM H2O2 for 30 min. Cell viability was determined 
as described in methods. Results of WT and Klura3∆ from Figure 3.16 are included for comparison. Values 
are mean ± SD of at least three independent experiments. 
 
 
 
3.2.2. Studies at later growth phases 
 
Bearing in mind the possible application on orotic acid production of the new 
insights resulting from this part of the work, it was essential to further investigate 
oxidative stress resistance throughout growth. WT strain and Klura3∆ mutant were 
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then followed overtime from OD600 = 0.6 (starting point, T0). Growth is shown in 
Figure 3.19A and the relevant time points at the bottom of Figure 3.19. Viability 
tests were performed at several time points and, since the concentration of H2O2 
required to induce a visible effect increased substantially with culture growth, we 
chose to present data as the concentration of H2O2 required to produce 50% cell 
death (LC50) after 30 min exposure (Figure 3.19B and Table 3.2). These assays 
were performed only up to 36h but seemed sufficient to demonstrate maximum 
values have been reached. Opposite to what was observed at T0, the mutant 
Klura3∆ exhibited an increased resistance to H2O2 at latter stages of growth in 
relation to WT. Maximum LC50 for WT was 650 mM of H2O2, but 50% of Klura3∆ 
cells were able to survive a striking concentration of 3.6 M already at 24 h. To our 
knowledge, there is no other yeast with such level of resistance to H2O2. A 
possible biotechnological application of this attribute should be considered but we 
did not examine its potential since it falls out the scope of this work. 
Measurements of oxygen consumption of both strains were made to determine if it 
was elevated in Klura3∆ possibly due to an increased respiratory metabolism or a 
higher activity of KlUra9p DHODase. In that case, it would suggest an elevated 
ROS production and subsequent oxidative stress response that could help explain 
the resistance of Klura3∆ to H2O2. However, other factors must be associated with 
Klura3∆ phenotype since no relevant difference was observed compared to WT, 
and actually, a minor decrease in oxygen consumption was observed for Klura3∆ 
after 18 h (Figure 3.19C). Catalase activity was measured and a significant 
increase was observed for Klura3∆, which at 24 h showed a catalase activity 
4.5 fold higher to the observed in WT (Figure 3.19D). Catalase activity and H2O2 
LC50 throughout the growth clearly correlate. At 12 h (T1), the phenotypic 
divergence of Klura3∆ starts to be visible and maximal difference is already 
observed at 24 h (T2), after which, the values for both strains remain steady. 
These results suggest that the remarkable resistance of Klura3∆ to H2O2 may be 
attributed to the cellular catalase activity. 
Cellular detoxification of H2O2 is mostly carried out by the enzymatic action of 
catalases and, as in S. cerevisiae, genes for both peroxisomal (KlCTA1) and 
cytosolic (KlCTT1) catalases are present in K. lactis. To determine the relative 
contribution of each of the K. lactis enzymes (KlCta1p and KlCtt1p) or the 
existence of other unknown catalase, several catalase mutants were generated
	  	   59	  
Figure 3.19 
 
 
 
Figure 3.19 Determination at several time points of K. lactis WT and Klura3∆ growth (A) of their resistance to 
H2O2 (B), O2 consumption rate (C) and catalase activity  (D). Resistance to H2O2 was determined at each 
point by identifying the concentration required to induce 50% cell death (LC50) after 30 min exposure 
(Table 3.2). Values are mean ± SD of at least three independent experiments. 
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Table 3.2 
Table 3.2 Concentration of H2O2 required for 50 % cell death after 30 min exposure at several time points of 
K. lactis WT and Klura3∆ growth.  
 
 WT Klura3∆ 
Time (h) H2O2 %Viabilitity H2O2 %Viabilitity 
     0    (T0) 6 mM 54   ± 7 3.5 mM 54   ± 4 
     6.5 25 mM 55   ± 9 30 mM 54   ± 6 
   12    (T1) 80 mM 54   ± 4 340 mM 48   ± 1 
   18 370 mM 54   ± 4 1.7 M 56   ± 3 
   24    (T2) 600 mM 53   ± 5 3.6 M 46   ± 2 
   36 650 mM 
 
52   ± 6 3.7 M 49   ± 3 
 
 
 
and activity was measured at T1 and T2 (Figure 3.20). Single catalase mutants 
(Klcta1∆ and Klctt1∆) had a cell growth similar to that of WT cells (Figure 3.20A) 
but a decreased catalase activity at both time points (Figure 3.20B). A very similar 
pattern, but at considerably higher levels of activity, was also observed for 
Klcta1∆Klura3∆ and Klctt1∆Klura3∆ when compared to Klura3∆, despite no 
difference in growth. It seems that in WT and Klura3∆, both KlCta1p and KlCtt1p 
are implicated in the catalase activity measured. For Klura3∆ in particular, the 
contribution of KlCtt1p seems to be greater than KlCta1p when maximum catalase 
activity was detected at T2 but the contrary was observed at T1 when the effect of 
a strong catalase activity is only starting to emerge. Catalase activity was not 
detected in neither of the mutants with both catalase genes deleted, 
Klcta1∆Klctt1∆ and Klcta1∆Klctt1∆Klura3∆, ruling out the existence of other 
catalase in K. lactis. 
Growth of Klcta1∆Klctt1∆ was similar to WT cells (Figure 3.20A) in spite of the 
absence of catalase activity. However, growth of Klcta1∆Klctt1∆Klura3∆ cells was 
significantly decreased when compared to that of Klura3∆ cells. This is probably 
related with the decrease of orotic acid production observed in the triple mutant, 
which was close to 20% [data not shown]. While in WT the catalases seem to be 
dispensable under the conditions used, its activity is essential to provide normal 
growth in Klura3∆. The glutathione system also acts as a cellular defense 
mechanism in the elimination of H2O2 and may be sufficient to prevent its toxic 
effects in Klcta1∆Klctt1∆ cells. On the other hand, it is possible that Klura3∆ is 
subjected to an abnormal amount of H2O2 and, therefore, catalase activity is 
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required for this mutant to cope with the oxidative stress and to efficiently produce 
orotic acid. 
 
 
 
Figure 3.20 
 
 
Figure 3.20 Growth (A) and catalase activity at T1 and T2 (B) of WT and Klura3∆ derived mutants with single 
(Klcta1∆ or Klctt1∆) or double catalase gene deletion. Symbol “*“ represents no catalase activity detected. 
Results of WT and Klura3∆ from Figure 3.19 are included for comparison. Values are mean ± SD of at least 
three independent experiments. 
 
 
 
To investigate if the phenotype found at later growth stages was unique to Klura3∆ 
and to evaluate if the putative link to the DHODases persisted, catalase activity 
was measured in other pyrimidines mutants at T1 and T2 (Figure 3.21). With 
respect to the pyrimidines mutants with interruption of the pathway at steps prior to 
that catalyzed by Klura3p, the Klura2∆ mutant that has the initial steps of the 
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pathway interrupted, was also included in this study together with Klura1∆Klura9∆ 
and Klura5∆. Growth of these three mutants was similar to that of Klura3∆ 
(Figure 3.21A). As observed in Klura3∆ cells, Klura2∆, Klura1∆Klura9∆ and 
Klura5∆ mutants showed a considerable increase in catalase activity at both T1 
and T2 when compared to WT (Figure 3.21B). This increase was similar in the 
three mutants but they exhibited a catalase activity at T2 inferior to that of Klura3∆ 
cells. Additional deletion of any of the genes coding for the two distinct DHODases 
(Klura1∆Klura3∆ and Klura9∆Klura3∆) again altered the Klura3∆ phenotype 
(Figure 3.21B). Their effect was characterized by a drop in catalase activity that 
became close to values found at T2 in all other mutants besides Klura3∆. 
 
 
 
Figure 3.21 
 
 
Figure 3.21 Growth (A) and catalase activity at T1 and T2 (B) of pyrimidines mutants with interruption of the 
pathway at steps prior to that catalyzed by Klura3p (Klura2∆, Klura1∆Klura9∆, Klura5∆, Klura1∆Klura3∆ and 
Klura9∆Klura3∆). Results of WT and Klura3∆ from Figure 3.19 are included for comparison. Values are mean 
± SD of at least three independent experiments. 
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We have postulated that the presence of a DHODase linked to the mitochondria 
together with a probable higher DHODase activity in orotic acid producing mutants 
could be responsible for an increased ROS production leading to the induction of 
an oxidative stress response. Under the conditions used, the action of DHODases 
enzymatic step is apparently not playing any role in that effect since the orotic acid 
producing mutant, Klura5∆, and the mutants with no DHODase activity, Klura2∆ or 
Klura1∆Klura9∆, shared the same phenotype. An apparently similar phenotype 
was also observed when each DHODase gene was deleted in the orotic acid 
producing mutant, Klura3∆. 
These results show that a non-functional de novo pyrimidines synthesis pathway 
leads to a strong increase in catalase activity regardless of the step interrupted. 
However, a more marked increase of catalase activity at T2 was observed in 
Klura3∆, suggesting that specific mechanisms may be involved in this particular 
mutant. Furthermore, the phenotypes of Klura3∆ were similarly altered, but in 
apparently opposite directions when comparing T0 (increased resistance to H2O2) 
with T2 (decreased catalase activity), by further deleting either KlURA1 or 
KlURA9, which code for two enzymatically distinct DHODases. This indicates that 
further deletion of either DHODases genes may be disturbing a possible 
connection that requires the three genes. The apparently opposite phenotypic 
outcomes at T0 and T2 may be a consequence of such putative connection being 
played at distinct metabolic phases of cells since, with respect to pyrimidines 
synthesis, at T0 cells are most likely using the salvage pathway and at T2 the 
de novo pyrimidines synthesis may be fully active. 
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4. CHAPTER IV – General Discussion and Future Perspectives 
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4.1. Orotic acid production by K. lactis mutants 
 
 
4.1.1. Production using YPD based media 
 
Studies on flasks and bioreactor using YPD based media demonstrated that the 
K. lactis Klura3∆ and Klura5∆ mutants are able to accumulate in the growth 
medium considerable amounts of orotic acid. The concentration of orotic acid, as 
well as the time required to achieve it (6.7 g/L after 96 h), are comparable to the 
ones obtained with a similar mutant strain (ATCC 14275) of the industrially 
valuable C. glutamicum (8.2 g/L after 120 h). The studies on YPD based media 
were decisive for the initial validation of the biotechnological potential of the 
K. lactis pyrimidines mutants as orotic acid producing microorganisms. The 
amounts obtained were highly relevant and efforts should be taken for further 
medium and strain optimizations that may ultimately lead to an even more efficient 
and industrially competitive production process when compared to C. glutamicum. 
Those studies were also proven very important regarding the information attained. 
As discussed below, it could be used in the subsequent optimizations steps and 
the development of parallel lines of research to deepen the understanding of key 
mechanisms that could be improved for orotic acid production.  
Production scale-up using K. lactis has been made and was proven useful for the 
biotechnology industry. According to the tests on the production of orotic acid in a 
bioreactor we foresee that the scaling-up of this process should be simple to 
accomplish and only general issues regarding adaptation to large tanks would be 
required. More importantly was the high reproducibility of orotic acid production in 
flask and bioreactor once the optimal conditions in both cases have been 
determined. Thus, flask experiments to fully elaborate the composition of a 
production medium are expected to be replicated in the bioreactor at any stage of 
the development process. This would eliminate the need for an expensive line of 
parallel bioreactors or minimize time-consuming experiments in a single bioreactor 
by simply testing several conditions in a single experiment using flask cultures.  
In addition to media optimization, this feature is also an advantage for the genetic 
optimization of K. lactis mutant strains. K. lactis is closely related to the 
well-studied yeast S. cerevisiae, its genome has been fully sequenced and many 
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specific genetic tools have been developed. Identification of genetic targets and 
directed mutagenesis could be easily achieved and already assessed with this 
YPD / MOPS flask system. Differences in the efficiency of orotic acid production 
observed in this media should be also visible using other optimized media that 
could be later accomplished. Moreover, it could also be further and easily adapted 
for screening in high-throughput systems of mutants that have been randomly 
generated. We demonstrated that production in a closed and controlled 2 L 
bioreactor with 1 L media could be successfully downscaled to flasks containing 
20 ml media. Testing if sufficient media aeration could be achieved using 24, 48 or 
even 96 deep well plates specifically developed for cell growth, the system could 
be used for screening a great number of mutants in a short period of time through 
a less laborious process. Instead of using the time-consuming HPLC procedure for 
the accurate determination of orotic acid concentration, easy and quick 
measurements at OD278 of all cell free samples in a microplate reader should be 
sufficient to evaluate rate of production and final amounts obtained. 
K. lactis possesses a DHODase (KlUra9p) linked to the mitochondria. We showed 
that best production of orotic acid occurred under higher aeration conditions above 
the ones that are sufficient for regular growth. Using those conditions, we 
demonstrated that the KlUra9p is the most relevant DHODase. It is feasible that 
the particular features of the step catalyzed by the DHODases in K. lactis are the 
major contributors for its exceptional ability to produce large amounts of orotic 
acid. Since this is the limiting step of the de novo pyrimidines biosynthetic 
pathway, genetic engineering of orotic acid producing mutants to increase 
expression of KlUra9p may reveal an important improvement in the production 
system. 
Since it is very unlikely that orotic acid crosses the cell membrane of K. lactis by 
diffusion, it is probably making use of a transport system present in the membrane. 
The identification of the transporter involved in the secretion of orotic acid is crucial 
for the understanding of the entire process and may reveal another distinct 
attribute of K. lactis that is determinant for the ability of this yeast to accumulate 
large amounts of orotic acid in the growth media. Also, it would be an important 
candidate for genetic improvement of K. lactis strains by increasing its presence 
on the membrane. 
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Optimum pH for K. lactis growth is known to be pH 4.5 – 5 but the optimal pH for 
orotic acid production was found to be at or close to pH 7. However, growth at 
neutral pH by Klura3∆ mutant cells was not affected. Optimal production of 
biomass and orotic acid could be achieved at same pH conditions favoring 
therefore the process yields. It would be important to unravel if pH affects specific 
mechanisms involved in the production of orotic acid or is enhancing the 
production and accumulation by promoting its secretion across the membrane. 
According to the studies performed in the bioreactor, Klura3∆ mutant cells 
continued to accumulate orotic acid in the media after glucose has been depleted 
and growth stopped. It is possible that de novo pyrimidines pathway in this mutant 
is not effectively down regulated after growth has ceased and cells continue 
production as long as substrates are readily available or generated from other 
carbon sources, such as metabolites derived from glucose degradation or other 
amino acids. We should also recognize that the mechanism of orotic acid 
secretion might be playing the major role on this effect. Transport across the 
membrane could be a limiting factor and once accumulated inside the cells, the 
orotic acid would continue to be secreted to the media long after its production has 
stopped or became residual. 
Yet, we do not know whether it is any specific metabolic or regulatory feature of 
the de novo pyrimidines biosynthetic pathway, the presence of an unknown 
transporter or other distinctive characteristic of K. lactis, that account for the 
amount of orotic acid produced and accumulated in the growth media by the 
Klura3∆ and Klura5∆ mutants. The uncover of the exceptional feature or the 
possible interplay between several particular characteristics may provide a main 
focus for the optimization of the orotic acid production system. 
 
 
4.1.2. Production using low cost industrial media 
 
Studies on the production of orotic acid using YPD based media were important 
for the initial assessment of the potential of K. lactis mutants as orotic acid 
producing microorganisms. Growth and production on the YPD system can also 
provide the standards for further research in the fundamental aspects that are 
involved in the production and secretion of orotic acid. However, it would not be 
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used at an industrial production level due to its costs as a large-scale raw material. 
The efficiency of production using industrial by-products as low cost constituents 
of the production media had to be evaluated to confirm its value for the 
biotechnology industry. 
We have chosen molasse as the main carbon source but the use of CWP must not 
be discarded. The unique ability of K. lactis to use lactose together with the local 
availability and price of unprocessed cheese whey or CWP may end up making it 
more attractive than molasse. With respect to the nitrogen source, urea was found 
to be the best option since it clearly led to a higher orotic acid production when 
compared to (NH4)2SO4. We identified CSL as a very important constituent since 
its use seems to supplement all other nutrients required for the growth of K. lactis 
mutant strains. Growth of K. lactis Klura3∆ in a buffered media containing 4% (v/v) 
CSL, 3.4% (v/v) molasse and 0.25% (w/v) urea, which provided a combined total 
of 20 g/L sugars, led to the production of 4.5 g/L of orotic acid after 80 h. Under 
similar growth conditions and culture time the production in YPD media containing 
20 g/L glucose was shown to be only 3.4 g/L. Regarding the C. glutamicum mutant 
strain ATCC 14275 it was claimed that it can produce in flask cultures 8.2 g/L of 
orotic acid using low cost production media. However, to reach such values it 
takes 120 h and seems to require 100 g/L of sugars. This indicates that the 
production obtained with K. lactis Klura3∆ is extremely promising taking that full 
media optimization has not been performed. 
The results already obtained enforce the biotechnological potential of pyrimidines 
mutants of K. lactis to produce high amounts of orotic acid through a low cost 
industrial process. We considered they should be the starting point for a 
comprehensive work to design and execute experimental matrixes in order to 
identify and determine the optimum concentration of other general and specific 
nutrients relevant for orotic acid production. As previously demonstrated with YPD 
based medium, a multitude of media composition could be easily and exhaustively 
tested in flasks, which would then be closely replicated in the bioreactor expecting 
only minor or straightforward adaptations. For most of the compounds to be tested 
in flasks, such as vitamins and inorganic salts, ordinary growth conditions and 
equipment could be used. Bicarbonate is one of the initial substrates of the 
pyrimidines pathway and it is a cheap raw material, mostly as calcium carbonate 
(limestone powder) but also as sodium bicarbonate, which makes it one of the 
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most promising nutrients to be tested. Bicarbonate can be used not only as 
substrate but has the advantage of serving as a pH buffer at neutral pH and could 
therefore diminish the requirements or even completely eliminate the need to use 
the expensive MOPS buffer for pH stabilization in flask cultures. However, to 
maintain bicarbonate in solution, a specialized CO2 growth chamber would be 
required to allow a controlled and closed environment similar to what can be 
achieved in a bioreactor. 
However, prior the experimental work regarding optimization of the production 
media, K. lactis Klura3∆ or Klura5∆ should be further genetically manipulated to 
address the inhibition of orotic acid production. A genetically modified strain less 
prone to inhibition would significantly alter the limitations for CSL utilization, and 
consequently, the requirements for all other media constituents. Using such an 
optimized strain, it is reasonable to consider that higher concentrations of CSL 
would be allowed in solution having less interference in orotic acid production. 
Taking into account the strong growth achieved with this industrial by-product, we 
consider that addition of concentrated CSL through a fed batch system able to 
maintain optimum and non-inhibiting concentrations, the needs for other media 
constituents could be considerably diminished. Ultimately, it is possible to consider 
that a fed batch system with a production media composed solely of cheap CSL 
could be achieved. 
The presence and concentration of uracil and related pyrimidines in CSL has not 
been determined and full analytical examination should be performed but 
according to the strong growth observed in CSL by the pyrimidines-requiring 
K. lactis Klura3∆ mutant, it is most likely rich in such molecules. As in 
S. cerevisiae, the pyrimidines salvage pathway is expected to use uracil and the 
newly formed UTP may in turn inhibit the first step of the de novo pathway in 
K. lactis as well. Initial studies on the mechanisms of the feedback inhibition of 
CPSase and ATCase activities of Ura2p were made possible by the use of the 
uracil analogue, 5-fluorouracil (5-FU). S. cerevisiae mutants generated by 
UV mutagenesis that have been selected according to their increased resistance 
to 5-FU presented a decreased sensitivity to UTP inhibition [191, 192]. Mutations 
at several amino acids positions in Ura2p were identified and shown to completely 
eliminate the inhibition of ATCase activity by UTP. Since these amino acids are 
conserved in K. lactis KlUra2p we should test the effect of their substitution on 
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orotic acid production. Screening of randomly generated K. lactis mutants for their 
resistance to 5-FU should also be undertaken since mechanisms of inhibition in 
K. lactis may be different. Also important, it may reveal mutations of KlUra2p that 
could also abolish or at least diminish the inhibition of CPSase activity as well. 
 
 
4.2. Relation of the de novo pyrimidines biosynthetic pathway with 
oxidative stress response in K. lactis. 
 
Our results show that interruption of the de novo pyrimidines pathway in K. lactis 
affects oxidative stress resistance and catalase activity. The increase of catalase 
activity in these mutants may result from a specific adaptive response or from a 
general oxidative stress response. For future work though, it is important to 
distinguish two general phenotypes. One seems to result from the interruption of 
the de novo pathway up to the fifth step (KlURA5), since those mutants equally 
evolved from H2O2 resistance similar to WT at early exponential phase (T0; 
OD600=0.6) to an increased catalase activity at a later growth phase (T2; 24 h after 
T0). It seems reasonable to consider that interruption of the de novo pyrimidines 
pathway is merely promoting a particular metabolic mechanism or pathway 
containing a redox reaction that indirectly leads to an increased production of 
H2O2, which would in turn signal to an oxidative stress response.  
The other phenotype seems to result from the specific deletion of the KlURA3 
gene (interrupts the sixth step of the pyrimidine biosynthetic pathway) and may be 
related with a disturbance in an existing relation that requires KlURA3, KlURA1 
and KlURA9. The Klura3∆ mutant showed lower resistance to H2O2 at T0 and 
higher catalase activity at T2 (even when compared to that of any other of the 
pyrimidines mutants tested) associated with a striking increase of oxidative stress 
resistance. An additional deletion of any of the distinct DHODases genes led to an 
increase of H2O2 resistance at T0 but a lower catalase activity at T2. Moreover, 
single deletion of KlURA1 or KlURA9 also induced a decrease in the resistance to 
H2O2 at T0, as observed in Klura3∆. We should acknowledge that these effects 
may result from an alteration of an existing regulatory cross-talk between de novo 
pyrimidines pathway and the oxidative stress response that is dependent on the 
presence of the three genes. Further studies should be carried out to unravel the 
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nature of this putative relation and it would be important to understand if it relies on 
a direct or indirect involvement of the DHODases (KlUra9p and KlUra1p) and OMP 
decarboxilase (KlUra3p) and if other regulatory proteins or a specific effector 
metabolite, such as the pyrimidine intermediate OMP, are involved.  
The crucial and initial steps to continue with these studies would be to perform in 
all of K. lactis mutants already produced a comprehensive and full analysis on the 
redox status, oxidative damage, activity and gene expression of selected 
antioxidant defenses at T0 and T2. It should be determined the time when the shift 
from a possibly inhibited to a fully active de novo synthesis occurs and use it for 
the analysis instead of T1. The generation and inclusion of the double mutants 
Klura1∆Klura5∆ and Klura9∆Klura5∆ in this investigation must be considered. 
We presented the hypothesis that overproduction of orotic acid through the activity 
of the putatively mitochondrial KlUra9p DHODase would create additional 
oxidative pressure and therefore possibly compromise cell performance and 
production efficiency. Indeed, that seems to occur when both catalases genes are 
deleted in Klura3∆. However, the high level of catalase activity and the cell viability 
at extremely high concentrations of H2O2 suggests that the K. lactis Klura3∆ can 
effectively maintain the normal cellular redox balance under high orotic acid 
production conditions. Also, on the contrary to S. cerevisiae that under oxidative 
stress redirects glucose equivalents from glycolysis to the pentose phosphate 
pathway that is normally less active, K. lactis preferably uses the pentose 
phosphate pathway to consume glucose. The NADPH generated from the pentose 
phosphate pathway is decisive upon cellular exposure to an oxidative stress since 
it provides the reducing potential for most antioxidant and redox regulatory 
enzymes. Together with the observations of the strong and effective response to 
H2O2 exposure, it is possible that these features, that are most likely related, may 
also contribute to the robustness of K. lactis Klura3∆ as an excellent biological 
system for the production of orotic acid. 
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4.3. Concluding remarks 
 
 
Using YPD based media, growth conditions for the production in flask cultures 
were optimized and a high reproducibility with the bioreactor system was 
achieved, thus validating the use of the flask set-up for straightforward 
optimization of production media and strains. 
CSL and urea have been identified as promising candidates for the development 
of a low cost production media. CSL alone was shown to sustain an excellent 
growth of the pyrimidines-requiring Klura3∆ mutant but due to the inhibitory effect 
on orotic acid production its use was limited to low concentrations and was 
regarded as an important supplement to molasse or CWP. A decreased sensitivity 
to inhibition of the production strains should therefore be accomplished by genetic 
modification to improve production yields and allow the development of a cost 
effective CSL based media. 
We observed that the DHODase putatively linked to the respiratory chain is 
essential for the production of orotic acid, on the contrary to the cytosolic 
DHODase, and best production demands an oxygen supply above the levels that 
are sufficient for optimum cell growth. Also, a putative involvement of both 
DHODases and Klura3p with the oxidative stress response seems to occur. 
However, despite our results suggest that cells were indeed responding to an 
oxidative stress, other factors may be involved because interruption at any step of 
the de novo pyrimidines biosynthetic seems to be inducing a response. It is 
possible that even higher levels of orotic acid production would not pose a major 
problem to the cells regarding the maintenance of the redox balance. 
In this study, a new feature of K. lactis with high biotechnological potential has 
been discovered. Optimization of strains and growth conditions may establish the 
yeast K. lactis as a solid alternative to the bacteria C. glutamicum for the 
production of orotic acid. 
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